GO:0090304 | nucleic acid metabolic process | 43.72% (101/231) | 2.41 | 0.0 | 0.0 |
GO:0140513 | nuclear protein-containing complex | 31.17% (72/231) | 3.03 | 0.0 | 0.0 |
GO:0016070 | RNA metabolic process | 36.8% (85/231) | 2.62 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 49.35% (114/231) | 2.0 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 43.72% (101/231) | 2.11 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 58.44% (135/231) | 1.39 | 0.0 | 0.0 |
GO:0006396 | RNA processing | 26.84% (62/231) | 2.63 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 48.48% (112/231) | 1.62 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 44.16% (102/231) | 1.75 | 0.0 | 0.0 |
GO:0016071 | mRNA metabolic process | 21.21% (49/231) | 3.08 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 44.16% (102/231) | 1.7 | 0.0 | 0.0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 45.02% (104/231) | 1.63 | 0.0 | 0.0 |
GO:0080090 | regulation of primary metabolic process | 45.89% (106/231) | 1.56 | 0.0 | 0.0 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 38.1% (88/231) | 1.82 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 45.02% (104/231) | 1.58 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 43.72% (101/231) | 1.59 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 50.22% (116/231) | 1.38 | 0.0 | 0.0 |
GO:0031323 | regulation of cellular metabolic process | 45.89% (106/231) | 1.49 | 0.0 | 0.0 |
GO:0010468 | regulation of gene expression | 40.26% (93/231) | 1.65 | 0.0 | 0.0 |
GO:0051252 | regulation of RNA metabolic process | 34.63% (80/231) | 1.81 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 45.02% (104/231) | 1.45 | 0.0 | 0.0 |
GO:0003723 | RNA binding | 27.27% (63/231) | 2.07 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 58.44% (135/231) | 1.06 | 0.0 | 0.0 |
GO:0010556 | regulation of macromolecule biosynthetic process | 34.2% (79/231) | 1.68 | 0.0 | 0.0 |
GO:0010629 | negative regulation of gene expression | 16.88% (39/231) | 2.81 | 0.0 | 0.0 |
GO:0006397 | mRNA processing | 13.42% (31/231) | 3.3 | 0.0 | 0.0 |
GO:0009892 | negative regulation of metabolic process | 29.44% (68/231) | 1.87 | 0.0 | 0.0 |
GO:0043228 | non-membrane-bounded organelle | 30.74% (71/231) | 1.8 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 30.74% (71/231) | 1.8 | 0.0 | 0.0 |
GO:0005488 | binding | 80.09% (185/231) | 0.68 | 0.0 | 0.0 |
GO:0010605 | negative regulation of macromolecule metabolic process | 27.71% (64/231) | 1.93 | 0.0 | 0.0 |
GO:0005515 | protein binding | 68.4% (158/231) | 0.85 | 0.0 | 0.0 |
GO:1990904 | ribonucleoprotein complex | 17.75% (41/231) | 2.64 | 0.0 | 0.0 |
GO:0009987 | cellular process | 81.39% (188/231) | 0.64 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 63.2% (146/231) | 0.91 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 58.01% (134/231) | 0.99 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 61.04% (141/231) | 0.94 | 0.0 | 0.0 |
GO:0065007 | biological regulation | 66.23% (153/231) | 0.85 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 87.88% (203/231) | 0.53 | 0.0 | 0.0 |
GO:0048519 | negative regulation of biological process | 39.83% (92/231) | 1.38 | 0.0 | 0.0 |
GO:1903311 | regulation of mRNA metabolic process | 11.26% (26/231) | 3.43 | 0.0 | 0.0 |
GO:0008150 | biological_process | 87.88% (203/231) | 0.51 | 0.0 | 0.0 |
GO:0031326 | regulation of cellular biosynthetic process | 35.06% (81/231) | 1.5 | 0.0 | 0.0 |
GO:0009889 | regulation of biosynthetic process | 35.5% (82/231) | 1.47 | 0.0 | 0.0 |
GO:0005681 | spliceosomal complex | 9.96% (23/231) | 3.64 | 0.0 | 0.0 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 26.84% (62/231) | 1.79 | 0.0 | 0.0 |
GO:0005684 | U2-type spliceosomal complex | 7.79% (18/231) | 4.3 | 0.0 | 0.0 |
GO:0048522 | positive regulation of cellular process | 36.36% (84/231) | 1.39 | 0.0 | 0.0 |
GO:0048523 | negative regulation of cellular process | 32.03% (74/231) | 1.52 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 50.65% (117/231) | 1.03 | 0.0 | 0.0 |
GO:0034660 | ncRNA metabolic process | 15.58% (36/231) | 2.52 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 50.65% (117/231) | 1.02 | 0.0 | 0.0 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 22.08% (51/231) | 1.95 | 0.0 | 0.0 |
GO:0008380 | RNA splicing | 9.96% (23/231) | 3.41 | 0.0 | 0.0 |
GO:0010604 | positive regulation of macromolecule metabolic process | 26.84% (62/231) | 1.68 | 0.0 | 0.0 |
GO:0048518 | positive regulation of biological process | 40.26% (93/231) | 1.22 | 0.0 | 0.0 |
GO:0031324 | negative regulation of cellular metabolic process | 22.08% (51/231) | 1.89 | 0.0 | 0.0 |
GO:0005654 | nucleoplasm | 19.05% (44/231) | 2.06 | 0.0 | 0.0 |
GO:0031325 | positive regulation of cellular metabolic process | 25.97% (60/231) | 1.65 | 0.0 | 0.0 |
GO:0009893 | positive regulation of metabolic process | 28.14% (65/231) | 1.55 | 0.0 | 0.0 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 21.65% (50/231) | 1.84 | 0.0 | 0.0 |
GO:0016607 | nuclear speck | 9.09% (21/231) | 3.35 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 83.98% (194/231) | 0.48 | 0.0 | 0.0 |
GO:0061013 | regulation of mRNA catabolic process | 7.79% (18/231) | 3.7 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 62.34% (144/231) | 0.75 | 0.0 | 0.0 |
GO:1902494 | catalytic complex | 19.05% (44/231) | 1.97 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 64.94% (150/231) | 0.71 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 83.12% (192/231) | 0.48 | 0.0 | 0.0 |
GO:0034470 | ncRNA processing | 12.99% (30/231) | 2.53 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 58.44% (135/231) | 0.79 | 0.0 | 0.0 |
GO:0071840 | cellular component organization or biogenesis | 38.53% (89/231) | 1.15 | 0.0 | 0.0 |
GO:0051254 | positive regulation of RNA metabolic process | 19.48% (45/231) | 1.88 | 0.0 | 0.0 |
GO:0016043 | cellular component organization | 36.8% (85/231) | 1.17 | 0.0 | 0.0 |
GO:0016604 | nuclear body | 11.26% (26/231) | 2.7 | 0.0 | 0.0 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 13.42% (31/231) | 2.37 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 13.85% (32/231) | 2.31 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 25.11% (58/231) | 1.52 | 0.0 | 0.0 |
GO:2001141 | regulation of RNA biosynthetic process | 25.11% (58/231) | 1.48 | 0.0 | 0.0 |
GO:0043487 | regulation of RNA stability | 6.93% (16/231) | 3.58 | 0.0 | 0.0 |
GO:0000398 | mRNA splicing, via spliceosome | 6.49% (15/231) | 3.72 | 0.0 | 0.0 |
GO:0010608 | post-transcriptional regulation of gene expression | 11.69% (27/231) | 2.47 | 0.0 | 0.0 |
GO:0140098 | catalytic activity, acting on RNA | 10.82% (25/231) | 2.6 | 0.0 | 0.0 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 6.93% (16/231) | 3.5 | 0.0 | 0.0 |
GO:0006355 | regulation of DNA-templated transcription | 24.68% (57/231) | 1.46 | 0.0 | 0.0 |
GO:1903506 | regulation of nucleic acid-templated transcription | 24.68% (57/231) | 1.45 | 0.0 | 0.0 |
GO:0043488 | regulation of mRNA stability | 6.49% (15/231) | 3.64 | 0.0 | 0.0 |
GO:0061014 | positive regulation of mRNA catabolic process | 5.63% (13/231) | 4.02 | 0.0 | 0.0 |
GO:0000375 | RNA splicing, via transesterification reactions | 6.93% (16/231) | 3.47 | 0.0 | 0.0 |
GO:0006974 | cellular response to DNA damage stimulus | 12.12% (28/231) | 2.35 | 0.0 | 0.0 |
GO:0051246 | regulation of protein metabolic process | 18.61% (43/231) | 1.75 | 0.0 | 0.0 |
GO:0043226 | organelle | 62.77% (145/231) | 0.64 | 0.0 | 0.0 |
GO:1903313 | positive regulation of mRNA metabolic process | 6.49% (15/231) | 3.56 | 0.0 | 0.0 |
GO:0071013 | catalytic step 2 spliceosome | 5.63% (13/231) | 3.93 | 0.0 | 0.0 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 8.23% (19/231) | 3.01 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 62.34% (144/231) | 0.64 | 0.0 | 0.0 |
GO:0035770 | ribonucleoprotein granule | 8.23% (19/231) | 2.99 | 0.0 | 0.0 |
GO:0071014 | post-mRNA release spliceosomal complex | 3.9% (9/231) | 4.99 | 0.0 | 0.0 |
GO:0006281 | DNA repair | 9.96% (23/231) | 2.57 | 0.0 | 0.0 |
GO:0006401 | RNA catabolic process | 6.49% (15/231) | 3.43 | 0.0 | 0.0 |
GO:0051248 | negative regulation of protein metabolic process | 11.26% (26/231) | 2.34 | 0.0 | 0.0 |
GO:0000785 | chromatin | 8.66% (20/231) | 2.8 | 0.0 | 0.0 |
GO:0032502 | developmental process | 47.62% (110/231) | 0.82 | 0.0 | 0.0 |
GO:0009896 | positive regulation of catabolic process | 9.09% (21/231) | 2.7 | 0.0 | 0.0 |
GO:0031123 | RNA 3'-end processing | 5.19% (12/231) | 3.99 | 0.0 | 0.0 |
GO:0004386 | helicase activity | 6.93% (16/231) | 3.25 | 0.0 | 0.0 |
GO:0031331 | positive regulation of cellular catabolic process | 8.23% (19/231) | 2.86 | 0.0 | 0.0 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 10.82% (25/231) | 2.34 | 0.0 | 0.0 |
GO:0031329 | regulation of cellular catabolic process | 10.39% (24/231) | 2.35 | 0.0 | 0.0 |
GO:0003729 | mRNA binding | 15.15% (35/231) | 1.83 | 0.0 | 0.0 |
GO:0071011 | precatalytic spliceosome | 4.33% (10/231) | 4.17 | 0.0 | 0.0 |
GO:0003724 | RNA helicase activity | 4.76% (11/231) | 3.84 | 0.0 | 0.0 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 6.93% (16/231) | 2.95 | 0.0 | 0.0 |
GO:0009894 | regulation of catabolic process | 11.26% (26/231) | 2.11 | 0.0 | 0.0 |
GO:0071826 | ribonucleoprotein complex subunit organization | 6.93% (16/231) | 2.93 | 0.0 | 0.0 |
GO:0051726 | regulation of cell cycle | 11.69% (27/231) | 2.05 | 0.0 | 0.0 |
GO:0051641 | cellular localization | 17.32% (40/231) | 1.55 | 0.0 | 0.0 |
GO:0006996 | organelle organization | 20.35% (47/231) | 1.38 | 0.0 | 0.0 |
GO:0008186 | ATP-dependent activity, acting on RNA | 4.76% (11/231) | 3.69 | 0.0 | 0.0 |
GO:0019899 | enzyme binding | 16.45% (38/231) | 1.59 | 0.0 | 0.0 |
GO:0071005 | U2-type precatalytic spliceosome | 3.9% (9/231) | 4.22 | 0.0 | 0.0 |
GO:0006402 | mRNA catabolic process | 5.19% (12/231) | 3.43 | 0.0 | 0.0 |
GO:0051276 | chromosome organization | 7.79% (18/231) | 2.6 | 0.0 | 0.0 |
GO:0005694 | chromosome | 8.23% (19/231) | 2.5 | 0.0 | 0.0 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 6.06% (14/231) | 3.07 | 0.0 | 0.0 |
GO:0050684 | regulation of mRNA processing | 5.63% (13/231) | 3.23 | 0.0 | 0.0 |
GO:0022618 | ribonucleoprotein complex assembly | 6.49% (15/231) | 2.92 | 0.0 | 0.0 |
GO:0048856 | anatomical structure development | 36.8% (85/231) | 0.88 | 0.0 | 0.0 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 4.76% (11/231) | 3.6 | 0.0 | 0.0 |
GO:0071007 | U2-type catalytic step 2 spliceosome | 3.46% (8/231) | 4.5 | 0.0 | 0.0 |
GO:0050779 | RNA destabilization | 3.9% (9/231) | 4.13 | 0.0 | 0.0 |
GO:0061157 | mRNA destabilization | 3.9% (9/231) | 4.13 | 0.0 | 0.0 |
GO:0048869 | cellular developmental process | 19.48% (45/231) | 1.38 | 0.0 | 0.0 |
GO:0000974 | Prp19 complex | 3.03% (7/231) | 4.92 | 0.0 | 0.0 |
GO:0034248 | regulation of cellular amide metabolic process | 8.66% (20/231) | 2.34 | 0.0 | 0.0 |
GO:0034655 | nucleobase-containing compound catabolic process | 6.93% (16/231) | 2.71 | 0.0 | 0.0 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 13.42% (31/231) | 1.74 | 0.0 | 0.0 |
GO:0010564 | regulation of cell cycle process | 9.09% (21/231) | 2.25 | 0.0 | 0.0 |
GO:0032774 | RNA biosynthetic process | 6.49% (15/231) | 2.77 | 0.0 | 0.0 |
GO:0006417 | regulation of translation | 8.23% (19/231) | 2.36 | 0.0 | 0.0 |
GO:0044265 | cellular macromolecule catabolic process | 10.82% (25/231) | 1.96 | 0.0 | 0.0 |
GO:0009890 | negative regulation of biosynthetic process | 13.85% (32/231) | 1.66 | 0.0 | 0.0 |
GO:0097525 | spliceosomal snRNP complex | 3.9% (9/231) | 3.91 | 0.0 | 0.0 |
GO:0099080 | supramolecular complex | 10.39% (24/231) | 1.98 | 0.0 | 0.0 |
GO:0017148 | negative regulation of translation | 5.19% (12/231) | 3.15 | 0.0 | 0.0 |
GO:0031400 | negative regulation of protein modification process | 6.49% (15/231) | 2.71 | 0.0 | 0.0 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 9.52% (22/231) | 2.09 | 0.0 | 0.0 |
GO:0043933 | protein-containing complex organization | 12.99% (30/231) | 1.7 | 0.0 | 0.0 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 12.99% (30/231) | 1.69 | 0.0 | 0.0 |
GO:0016072 | rRNA metabolic process | 6.93% (16/231) | 2.56 | 0.0 | 0.0 |
GO:0031327 | negative regulation of cellular biosynthetic process | 13.42% (31/231) | 1.65 | 0.0 | 1e-06 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 5.19% (12/231) | 3.11 | 0.0 | 1e-06 |
GO:0033036 | macromolecule localization | 15.15% (35/231) | 1.52 | 0.0 | 1e-06 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3.9% (9/231) | 3.78 | 0.0 | 1e-06 |
GO:0034249 | negative regulation of cellular amide metabolic process | 5.19% (12/231) | 3.09 | 0.0 | 1e-06 |
GO:0009891 | positive regulation of biosynthetic process | 16.88% (39/231) | 1.41 | 0.0 | 1e-06 |
GO:0006357 | regulation of transcription by RNA polymerase II | 12.12% (28/231) | 1.75 | 0.0 | 1e-06 |
GO:0043412 | macromolecule modification | 25.11% (58/231) | 1.07 | 0.0 | 1e-06 |
GO:0120114 | Sm-like protein family complex | 3.9% (9/231) | 3.74 | 0.0 | 1e-06 |
GO:0006364 | rRNA processing | 6.49% (15/231) | 2.61 | 0.0 | 1e-06 |
GO:0051253 | negative regulation of RNA metabolic process | 12.12% (28/231) | 1.73 | 0.0 | 1e-06 |
GO:0010628 | positive regulation of gene expression | 9.52% (22/231) | 2.02 | 0.0 | 1e-06 |
GO:0051052 | regulation of DNA metabolic process | 7.36% (17/231) | 2.39 | 0.0 | 1e-06 |
GO:0003677 | DNA binding | 19.91% (46/231) | 1.24 | 0.0 | 1e-06 |
GO:0005730 | nucleolus | 11.69% (27/231) | 1.75 | 0.0 | 1e-06 |
GO:0031399 | regulation of protein modification process | 10.39% (24/231) | 1.87 | 0.0 | 1e-06 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 15.15% (35/231) | 1.45 | 0.0 | 2e-06 |
GO:0022402 | cell cycle process | 12.12% (28/231) | 1.66 | 0.0 | 2e-06 |
GO:0006325 | chromatin organization | 6.49% (15/231) | 2.51 | 0.0 | 2e-06 |
GO:0003682 | chromatin binding | 7.79% (18/231) | 2.22 | 0.0 | 2e-06 |
GO:0031328 | positive regulation of cellular biosynthetic process | 16.02% (37/231) | 1.36 | 0.0 | 3e-06 |
GO:1990234 | transferase complex | 9.96% (23/231) | 1.85 | 0.0 | 4e-06 |
GO:0022414 | reproductive process | 31.6% (73/231) | 0.84 | 0.0 | 4e-06 |
GO:0043005 | neuron projection | 6.93% (16/231) | 2.33 | 0.0 | 4e-06 |
GO:0060998 | regulation of dendritic spine development | 2.6% (6/231) | 4.6 | 0.0 | 4e-06 |
GO:0044270 | cellular nitrogen compound catabolic process | 6.93% (16/231) | 2.32 | 0.0 | 4e-06 |
GO:0046700 | heterocycle catabolic process | 6.93% (16/231) | 2.32 | 0.0 | 4e-06 |
GO:0070727 | cellular macromolecule localization | 13.42% (31/231) | 1.5 | 0.0 | 5e-06 |
GO:0008104 | protein localization | 12.55% (29/231) | 1.56 | 0.0 | 5e-06 |
GO:0071006 | U2-type catalytic step 1 spliceosome | 2.16% (5/231) | 5.14 | 0.0 | 6e-06 |
GO:0071012 | catalytic step 1 spliceosome | 2.16% (5/231) | 5.14 | 0.0 | 6e-06 |
GO:0051028 | mRNA transport | 3.9% (9/231) | 3.35 | 0.0 | 6e-06 |
GO:0034708 | methyltransferase complex | 3.9% (9/231) | 3.31 | 0.0 | 9e-06 |
GO:1901987 | regulation of cell cycle phase transition | 6.06% (14/231) | 2.45 | 0.0 | 9e-06 |
GO:0032501 | multicellular organismal process | 31.6% (73/231) | 0.81 | 0.0 | 9e-06 |
GO:0005829 | cytosol | 26.84% (62/231) | 0.91 | 0.0 | 9e-06 |
GO:0005682 | U5 snRNP | 2.16% (5/231) | 4.97 | 1e-06 | 1.1e-05 |
GO:0044093 | positive regulation of molecular function | 8.23% (19/231) | 1.97 | 1e-06 | 1.2e-05 |
GO:0040029 | epigenetic regulation of gene expression | 4.76% (11/231) | 2.83 | 1e-06 | 1.2e-05 |
GO:0030154 | cell differentiation | 12.99% (30/231) | 1.45 | 1e-06 | 1.4e-05 |
GO:0007276 | gamete generation | 5.63% (13/231) | 2.5 | 1e-06 | 1.5e-05 |
GO:0009057 | macromolecule catabolic process | 11.26% (26/231) | 1.59 | 1e-06 | 1.5e-05 |
GO:0140535 | intracellular protein-containing complex | 9.09% (21/231) | 1.81 | 1e-06 | 1.7e-05 |
GO:0033043 | regulation of organelle organization | 8.66% (20/231) | 1.87 | 1e-06 | 1.7e-05 |
GO:0045786 | negative regulation of cell cycle | 5.19% (12/231) | 2.61 | 1e-06 | 1.7e-05 |
GO:0048513 | animal organ development | 9.52% (22/231) | 1.75 | 1e-06 | 1.8e-05 |
GO:0016477 | cell migration | 4.33% (10/231) | 2.94 | 1e-06 | 1.9e-05 |
GO:0008094 | ATP-dependent activity, acting on DNA | 4.33% (10/231) | 2.92 | 1e-06 | 2e-05 |
GO:0060147 | regulation of post-transcriptional gene silencing | 2.6% (6/231) | 4.18 | 1e-06 | 2.1e-05 |
GO:0051338 | regulation of transferase activity | 6.06% (14/231) | 2.32 | 1e-06 | 2.3e-05 |
GO:0031981 | nuclear lumen | 3.9% (9/231) | 3.11 | 1e-06 | 2.4e-05 |
GO:0033365 | protein localization to organelle | 7.79% (18/231) | 1.96 | 1e-06 | 2.5e-05 |
GO:0036211 | protein modification process | 20.78% (48/231) | 1.03 | 1e-06 | 2.6e-05 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.6% (6/231) | 4.08 | 2e-06 | 3.1e-05 |
GO:0030619 | U1 snRNA binding | 1.73% (4/231) | 5.5 | 2e-06 | 3.1e-05 |
GO:0001932 | regulation of protein phosphorylation | 6.06% (14/231) | 2.26 | 2e-06 | 3.4e-05 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 3.9% (9/231) | 3.03 | 2e-06 | 3.7e-05 |
GO:0050657 | nucleic acid transport | 3.9% (9/231) | 3.03 | 2e-06 | 3.8e-05 |
GO:0050658 | RNA transport | 3.9% (9/231) | 3.03 | 2e-06 | 3.8e-05 |
GO:0003678 | DNA helicase activity | 3.46% (8/231) | 3.28 | 2e-06 | 3.8e-05 |
GO:0051236 | establishment of RNA localization | 3.9% (9/231) | 3.02 | 2e-06 | 3.9e-05 |
GO:1902680 | positive regulation of RNA biosynthetic process | 12.55% (29/231) | 1.4 | 2e-06 | 4.1e-05 |
GO:0065003 | protein-containing complex assembly | 10.39% (24/231) | 1.58 | 2e-06 | 4.1e-05 |
GO:0006405 | RNA export from nucleus | 3.03% (7/231) | 3.58 | 2e-06 | 4.2e-05 |
GO:0043631 | RNA polyadenylation | 2.6% (6/231) | 3.99 | 2e-06 | 4.3e-05 |
GO:0043484 | regulation of RNA splicing | 4.33% (10/231) | 2.78 | 2e-06 | 4.5e-05 |
GO:1902531 | regulation of intracellular signal transduction | 8.66% (20/231) | 1.74 | 3e-06 | 5.9e-05 |
GO:0051168 | nuclear export | 3.46% (8/231) | 3.18 | 3e-06 | 6e-05 |
GO:1903312 | negative regulation of mRNA metabolic process | 3.03% (7/231) | 3.5 | 3e-06 | 6e-05 |
GO:0031047 | gene silencing by RNA | 4.33% (10/231) | 2.73 | 3e-06 | 6.1e-05 |
GO:0031124 | mRNA 3'-end processing | 2.6% (6/231) | 3.88 | 4e-06 | 6.5e-05 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 6.49% (15/231) | 2.07 | 4e-06 | 6.7e-05 |
GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex | 2.16% (5/231) | 4.4 | 4e-06 | 7.1e-05 |
GO:0140657 | ATP-dependent activity | 7.79% (18/231) | 1.83 | 4e-06 | 7.5e-05 |
GO:0022607 | cellular component assembly | 14.72% (34/231) | 1.22 | 4e-06 | 7.6e-05 |
GO:0048870 | cell motility | 4.33% (10/231) | 2.69 | 4e-06 | 7.6e-05 |
GO:0007613 | memory | 2.6% (6/231) | 3.84 | 4e-06 | 7.6e-05 |
GO:0044877 | protein-containing complex binding | 8.66% (20/231) | 1.71 | 4e-06 | 7.6e-05 |
GO:0042770 | signal transduction in response to DNA damage | 3.03% (7/231) | 3.43 | 4e-06 | 7.8e-05 |
GO:0051128 | regulation of cellular component organization | 13.85% (32/231) | 1.26 | 5e-06 | 8.4e-05 |
GO:0048468 | cell development | 7.36% (17/231) | 1.88 | 5e-06 | 8.8e-05 |
GO:0051640 | organelle localization | 6.06% (14/231) | 2.13 | 5e-06 | 8.9e-05 |
GO:0045893 | positive regulation of DNA-templated transcription | 12.12% (28/231) | 1.36 | 5e-06 | 8.9e-05 |
GO:0019439 | aromatic compound catabolic process | 6.93% (16/231) | 1.95 | 5e-06 | 9e-05 |
GO:1990116 | ribosome-associated ubiquitin-dependent protein catabolic process | 1.73% (4/231) | 5.08 | 5e-06 | 9.4e-05 |
GO:0006379 | mRNA cleavage | 2.16% (5/231) | 4.3 | 6e-06 | 9.7e-05 |
GO:0051716 | cellular response to stimulus | 25.97% (60/231) | 0.82 | 6e-06 | 9.7e-05 |
GO:0033554 | cellular response to stress | 19.05% (44/231) | 1.01 | 6e-06 | 9.8e-05 |
GO:0022613 | ribonucleoprotein complex biogenesis | 3.46% (8/231) | 3.06 | 6e-06 | 0.000103 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 12.12% (28/231) | 1.35 | 6e-06 | 0.000103 |
GO:0007275 | multicellular organism development | 15.15% (35/231) | 1.17 | 6e-06 | 0.000105 |
GO:0000932 | P-body | 3.46% (8/231) | 3.05 | 6e-06 | 0.000105 |
GO:0071004 | U2-type prespliceosome | 2.16% (5/231) | 4.27 | 6e-06 | 0.000105 |
GO:0071010 | prespliceosome | 2.16% (5/231) | 4.27 | 6e-06 | 0.000105 |
GO:0070647 | protein modification by small protein conjugation or removal | 9.52% (22/231) | 1.56 | 7e-06 | 0.000114 |
GO:1901988 | negative regulation of cell cycle phase transition | 3.9% (9/231) | 2.79 | 7e-06 | 0.00012 |
GO:0006406 | mRNA export from nucleus | 2.6% (6/231) | 3.7 | 7e-06 | 0.00012 |
GO:0006338 | chromatin remodeling | 4.76% (11/231) | 2.44 | 7e-06 | 0.000122 |
GO:0045182 | translation regulator activity | 4.33% (10/231) | 2.59 | 8e-06 | 0.000126 |
GO:1902808 | positive regulation of cell cycle G1/S phase transition | 2.16% (5/231) | 4.2 | 8e-06 | 0.000128 |
GO:0031175 | neuron projection development | 3.03% (7/231) | 3.28 | 9e-06 | 0.000142 |
GO:0051649 | establishment of localization in cell | 10.82% (25/231) | 1.42 | 9e-06 | 0.000144 |
GO:0042325 | regulation of phosphorylation | 6.06% (14/231) | 2.05 | 9e-06 | 0.000149 |
GO:0010948 | negative regulation of cell cycle process | 4.33% (10/231) | 2.56 | 9e-06 | 0.000149 |
GO:0043633 | polyadenylation-dependent RNA catabolic process | 1.73% (4/231) | 4.88 | 1e-05 | 0.000156 |
GO:0044248 | cellular catabolic process | 15.15% (35/231) | 1.13 | 1e-05 | 0.000159 |
GO:0043021 | ribonucleoprotein complex binding | 3.9% (9/231) | 2.72 | 1.1e-05 | 0.000171 |
GO:0140097 | catalytic activity, acting on DNA | 4.76% (11/231) | 2.38 | 1.1e-05 | 0.000171 |
GO:0019220 | regulation of phosphate metabolic process | 6.93% (16/231) | 1.86 | 1.1e-05 | 0.000174 |
GO:0007614 | short-term memory | 1.3% (3/231) | 5.99 | 1.1e-05 | 0.000177 |
GO:0035097 | histone methyltransferase complex | 3.03% (7/231) | 3.22 | 1.1e-05 | 0.000178 |
GO:0051179 | localization | 23.81% (55/231) | 0.83 | 1.2e-05 | 0.000181 |
GO:0000075 | cell cycle checkpoint signaling | 3.46% (8/231) | 2.92 | 1.2e-05 | 0.000193 |
GO:0033044 | regulation of chromosome organization | 4.33% (10/231) | 2.51 | 1.3e-05 | 0.000198 |
GO:0019787 | ubiquitin-like protein transferase activity | 6.93% (16/231) | 1.84 | 1.3e-05 | 0.000201 |
GO:0051174 | regulation of phosphorus metabolic process | 6.93% (16/231) | 1.84 | 1.3e-05 | 0.000206 |
GO:0042127 | regulation of cell population proliferation | 7.79% (18/231) | 1.7 | 1.4e-05 | 0.00021 |
GO:0051347 | positive regulation of transferase activity | 3.9% (9/231) | 2.67 | 1.4e-05 | 0.000215 |
GO:1901361 | organic cyclic compound catabolic process | 6.93% (16/231) | 1.83 | 1.5e-05 | 0.000225 |
GO:0009059 | macromolecule biosynthetic process | 10.39% (24/231) | 1.4 | 1.6e-05 | 0.000237 |
GO:0043632 | modification-dependent macromolecule catabolic process | 6.93% (16/231) | 1.82 | 1.6e-05 | 0.000238 |
GO:0046540 | U4/U6 x U5 tri-snRNP complex | 2.16% (5/231) | 4.0 | 1.6e-05 | 0.000238 |
GO:0061029 | eyelid development in camera-type eye | 1.3% (3/231) | 5.82 | 1.7e-05 | 0.000251 |
GO:1904949 | ATPase complex | 3.03% (7/231) | 3.13 | 1.7e-05 | 0.000252 |
GO:0097526 | spliceosomal tri-snRNP complex | 2.16% (5/231) | 3.97 | 1.7e-05 | 0.000258 |
GO:0051247 | positive regulation of protein metabolic process | 8.23% (19/231) | 1.6 | 2e-05 | 0.000304 |
GO:0010977 | negative regulation of neuron projection development | 2.16% (5/231) | 3.92 | 2.1e-05 | 0.000306 |
GO:0006260 | DNA replication | 3.46% (8/231) | 2.79 | 2.4e-05 | 0.00035 |
GO:0097692 | histone H3-K4 monomethylation | 1.3% (3/231) | 5.67 | 2.4e-05 | 0.000351 |
GO:0009790 | embryo development | 9.96% (23/231) | 1.4 | 2.4e-05 | 0.000357 |
GO:0001046 | core promoter sequence-specific DNA binding | 2.16% (5/231) | 3.87 | 2.5e-05 | 0.000359 |
GO:0000228 | nuclear chromosome | 3.03% (7/231) | 3.04 | 2.5e-05 | 0.000371 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 6.93% (16/231) | 1.76 | 2.6e-05 | 0.000373 |
GO:0003712 | transcription coregulator activity | 5.19% (12/231) | 2.11 | 2.6e-05 | 0.00038 |
GO:0001933 | negative regulation of protein phosphorylation | 3.03% (7/231) | 3.03 | 2.7e-05 | 0.000384 |
GO:0065009 | regulation of molecular function | 12.12% (28/231) | 1.22 | 2.8e-05 | 0.000406 |
GO:0000077 | DNA damage checkpoint signaling | 2.6% (6/231) | 3.36 | 2.8e-05 | 0.000407 |
GO:0019538 | protein metabolic process | 23.38% (54/231) | 0.8 | 2.9e-05 | 0.000415 |
GO:0060149 | negative regulation of post-transcriptional gene silencing | 1.3% (3/231) | 5.53 | 3.2e-05 | 0.000459 |
GO:0000350 | generation of catalytic spliceosome for second transesterification step | 1.3% (3/231) | 5.53 | 3.2e-05 | 0.000459 |
GO:0008174 | mRNA methyltransferase activity | 1.3% (3/231) | 5.53 | 3.2e-05 | 0.000459 |
GO:0004842 | ubiquitin-protein transferase activity | 6.49% (15/231) | 1.8 | 3.3e-05 | 0.000461 |
GO:0006351 | DNA-templated transcription | 3.46% (8/231) | 2.72 | 3.3e-05 | 0.000461 |
GO:0009887 | animal organ morphogenesis | 3.9% (9/231) | 2.51 | 3.3e-05 | 0.000467 |
GO:0002101 | tRNA wobble cytosine modification | 0.87% (2/231) | 7.4 | 3.5e-05 | 0.000483 |
GO:0002127 | tRNA wobble base cytosine methylation | 0.87% (2/231) | 7.4 | 3.5e-05 | 0.000483 |
GO:0051130 | positive regulation of cellular component organization | 6.49% (15/231) | 1.79 | 3.7e-05 | 0.000515 |
GO:0097659 | nucleic acid-templated transcription | 3.46% (8/231) | 2.69 | 3.9e-05 | 0.000536 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 4.33% (10/231) | 2.32 | 3.9e-05 | 0.000537 |
GO:1902369 | negative regulation of RNA catabolic process | 2.6% (6/231) | 3.27 | 3.9e-05 | 0.000541 |
GO:0008284 | positive regulation of cell population proliferation | 5.19% (12/231) | 2.05 | 4e-05 | 0.000545 |
GO:0048598 | embryonic morphogenesis | 4.33% (10/231) | 2.31 | 4e-05 | 0.000547 |
GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 2.6% (6/231) | 3.26 | 4.2e-05 | 0.000565 |
GO:0060964 | regulation of miRNA-mediated gene silencing | 1.73% (4/231) | 4.36 | 4.3e-05 | 0.000575 |
GO:0005849 | mRNA cleavage factor complex | 2.16% (5/231) | 3.7 | 4.3e-05 | 0.000576 |
GO:2000234 | positive regulation of rRNA processing | 1.3% (3/231) | 5.4 | 4.3e-05 | 0.000577 |
GO:0000354 | cis assembly of pre-catalytic spliceosome | 1.3% (3/231) | 5.4 | 4.3e-05 | 0.000577 |
GO:0045814 | negative regulation of gene expression, epigenetic | 3.03% (7/231) | 2.92 | 4.4e-05 | 0.00059 |
GO:0120025 | plasma membrane bounded cell projection | 8.66% (20/231) | 1.46 | 4.7e-05 | 0.000622 |
GO:0043085 | positive regulation of catalytic activity | 5.19% (12/231) | 2.02 | 5e-05 | 0.000655 |
GO:0007346 | regulation of mitotic cell cycle | 5.19% (12/231) | 2.02 | 5e-05 | 0.000655 |
GO:0070603 | SWI/SNF superfamily-type complex | 2.6% (6/231) | 3.21 | 5.1e-05 | 0.000675 |
GO:0007281 | germ cell development | 3.46% (8/231) | 2.62 | 5.4e-05 | 0.000706 |
GO:0098687 | chromosomal region | 3.9% (9/231) | 2.42 | 5.4e-05 | 0.000707 |
GO:0030620 | U2 snRNA binding | 1.3% (3/231) | 5.29 | 5.6e-05 | 0.000721 |
GO:0080009 | mRNA methylation | 1.3% (3/231) | 5.29 | 5.6e-05 | 0.000721 |
GO:0010494 | cytoplasmic stress granule | 3.03% (7/231) | 2.86 | 5.6e-05 | 0.000723 |
GO:0010563 | negative regulation of phosphorus metabolic process | 3.46% (8/231) | 2.61 | 5.6e-05 | 0.000724 |
GO:0045936 | negative regulation of phosphate metabolic process | 3.46% (8/231) | 2.61 | 5.6e-05 | 0.000724 |
GO:0006261 | DNA-templated DNA replication | 2.6% (6/231) | 3.18 | 5.7e-05 | 0.000728 |
GO:0046907 | intracellular transport | 9.09% (21/231) | 1.39 | 6.2e-05 | 0.000791 |
GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle | 1.73% (4/231) | 4.19 | 6.7e-05 | 0.00086 |
GO:0001222 | transcription corepressor binding | 1.3% (3/231) | 5.18 | 7.1e-05 | 0.000886 |
GO:0043634 | polyadenylation-dependent ncRNA catabolic process | 1.3% (3/231) | 5.18 | 7.1e-05 | 0.000886 |
GO:0071029 | nuclear ncRNA surveillance | 1.3% (3/231) | 5.18 | 7.1e-05 | 0.000886 |
GO:0071046 | nuclear polyadenylation-dependent ncRNA catabolic process | 1.3% (3/231) | 5.18 | 7.1e-05 | 0.000886 |
GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA | 1.3% (3/231) | 5.18 | 7.1e-05 | 0.000886 |
GO:0042326 | negative regulation of phosphorylation | 3.03% (7/231) | 2.81 | 7e-05 | 0.000896 |
GO:0048609 | multicellular organismal reproductive process | 7.79% (18/231) | 1.51 | 7.5e-05 | 0.000939 |
GO:0031490 | chromatin DNA binding | 2.6% (6/231) | 3.07 | 8.7e-05 | 0.001082 |
GO:0031570 | DNA integrity checkpoint signaling | 2.6% (6/231) | 3.07 | 8.7e-05 | 0.001082 |
GO:0044666 | MLL3/4 complex | 1.3% (3/231) | 5.08 | 8.8e-05 | 0.001086 |
GO:0061000 | negative regulation of dendritic spine development | 1.3% (3/231) | 5.08 | 8.8e-05 | 0.001086 |
GO:0031345 | negative regulation of cell projection organization | 2.16% (5/231) | 3.48 | 9.1e-05 | 0.001116 |
GO:1902806 | regulation of cell cycle G1/S phase transition | 2.6% (6/231) | 3.06 | 9.1e-05 | 0.001119 |
GO:0019904 | protein domain specific binding | 5.63% (13/231) | 1.83 | 9.3e-05 | 0.001135 |
GO:0045787 | positive regulation of cell cycle | 4.33% (10/231) | 2.15 | 0.0001 | 0.001224 |
GO:0050730 | regulation of peptidyl-tyrosine phosphorylation | 1.73% (4/231) | 4.05 | 0.000101 | 0.001233 |
GO:0006913 | nucleocytoplasmic transport | 3.46% (8/231) | 2.49 | 0.000102 | 0.001234 |
GO:0001734 | mRNA (N6-adenosine)-methyltransferase activity | 0.87% (2/231) | 6.82 | 0.000104 | 0.001242 |
GO:0021861 | forebrain radial glial cell differentiation | 0.87% (2/231) | 6.82 | 0.000104 | 0.001242 |
GO:0060019 | radial glial cell differentiation | 0.87% (2/231) | 6.82 | 0.000104 | 0.001242 |
GO:0000388 | spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) | 0.87% (2/231) | 6.82 | 0.000104 | 0.001242 |
GO:0140096 | catalytic activity, acting on a protein | 18.61% (43/231) | 0.85 | 0.000103 | 0.001247 |
GO:0016570 | histone modification | 5.19% (12/231) | 1.9 | 0.000108 | 0.001281 |
GO:0051169 | nuclear transport | 3.46% (8/231) | 2.48 | 0.000108 | 0.001284 |
GO:0070063 | RNA polymerase binding | 2.16% (5/231) | 3.42 | 0.000109 | 0.001291 |
GO:0120036 | plasma membrane bounded cell projection organization | 3.9% (9/231) | 2.29 | 0.00011 | 0.001301 |
GO:0050807 | regulation of synapse organization | 2.6% (6/231) | 3.0 | 0.000114 | 0.00134 |
GO:0043549 | regulation of kinase activity | 3.9% (9/231) | 2.28 | 0.000116 | 0.001358 |
GO:0023057 | negative regulation of signaling | 8.66% (20/231) | 1.36 | 0.000118 | 0.001384 |
GO:0010648 | negative regulation of cell communication | 8.66% (20/231) | 1.36 | 0.000121 | 0.001408 |
GO:0009792 | embryo development ending in birth or egg hatching | 3.9% (9/231) | 2.27 | 0.000121 | 0.001412 |
GO:0016074 | sno(s)RNA metabolic process | 1.73% (4/231) | 3.98 | 0.000122 | 0.001417 |
GO:1900368 | regulation of post-transcriptional gene silencing by RNA | 1.73% (4/231) | 3.98 | 0.000122 | 0.001417 |
GO:1903047 | mitotic cell cycle process | 6.06% (14/231) | 1.7 | 0.000126 | 0.001454 |
GO:0010586 | miRNA metabolic process | 1.3% (3/231) | 4.9 | 0.00013 | 0.001497 |
GO:0000389 | mRNA 3'-splice site recognition | 1.3% (3/231) | 4.9 | 0.00013 | 0.001497 |
GO:1903046 | meiotic cell cycle process | 5.63% (13/231) | 1.78 | 0.000131 | 0.001499 |
GO:0015931 | nucleobase-containing compound transport | 3.9% (9/231) | 2.25 | 0.000133 | 0.001521 |
GO:0048583 | regulation of response to stimulus | 22.51% (52/231) | 0.73 | 0.000136 | 0.001548 |
GO:0008134 | transcription factor binding | 5.19% (12/231) | 1.86 | 0.000136 | 0.00155 |
GO:0003727 | single-stranded RNA binding | 3.46% (8/231) | 2.42 | 0.000142 | 0.001609 |
GO:0042995 | cell projection | 8.66% (20/231) | 1.34 | 0.000144 | 0.00163 |
GO:0006414 | translational elongation | 2.16% (5/231) | 3.33 | 0.000146 | 0.001642 |
GO:0031593 | polyubiquitin modification-dependent protein binding | 1.73% (4/231) | 3.91 | 0.000146 | 0.001644 |
GO:0044057 | regulation of system process | 3.03% (7/231) | 2.63 | 0.000151 | 0.001689 |
GO:0080008 | Cul4-RING E3 ubiquitin ligase complex | 2.6% (6/231) | 2.92 | 0.000153 | 0.001705 |
GO:0033120 | positive regulation of RNA splicing | 2.16% (5/231) | 3.32 | 0.000154 | 0.001713 |
GO:0048232 | male gamete generation | 3.46% (8/231) | 2.4 | 0.000154 | 0.001716 |
GO:0071103 | DNA conformation change | 2.6% (6/231) | 2.91 | 0.000159 | 0.001761 |
GO:0034250 | positive regulation of cellular amide metabolic process | 3.46% (8/231) | 2.39 | 0.000162 | 0.001794 |
GO:0035556 | intracellular signal transduction | 8.23% (19/231) | 1.37 | 0.000164 | 0.001812 |
GO:0007507 | heart development | 2.16% (5/231) | 3.28 | 0.000172 | 0.001885 |
GO:0035196 | miRNA processing | 2.16% (5/231) | 3.28 | 0.000172 | 0.001885 |
GO:2000177 | regulation of neural precursor cell proliferation | 1.73% (4/231) | 3.85 | 0.000174 | 0.001899 |
GO:0016592 | mediator complex | 2.16% (5/231) | 3.27 | 0.000181 | 0.001979 |
GO:0006352 | DNA-templated transcription initiation | 2.16% (5/231) | 3.25 | 0.000191 | 0.002081 |
GO:0016567 | protein ubiquitination | 7.36% (17/231) | 1.45 | 0.000198 | 0.002145 |
GO:0004843 | cysteine-type deubiquitinase activity | 2.16% (5/231) | 3.23 | 0.000202 | 0.002181 |
GO:0071076 | RNA 3' uridylation | 0.87% (2/231) | 6.4 | 0.000207 | 0.002205 |
GO:0001555 | oocyte growth | 0.87% (2/231) | 6.4 | 0.000207 | 0.002205 |
GO:0002946 | tRNA C5-cytosine methylation | 0.87% (2/231) | 6.4 | 0.000207 | 0.002205 |
GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity | 0.87% (2/231) | 6.4 | 0.000207 | 0.002205 |
GO:0030623 | U5 snRNA binding | 0.87% (2/231) | 6.4 | 0.000207 | 0.002205 |
GO:0033550 | MAP kinase tyrosine phosphatase activity | 0.87% (2/231) | 6.4 | 0.000207 | 0.002205 |
GO:0045930 | negative regulation of mitotic cell cycle | 3.03% (7/231) | 2.55 | 0.000213 | 0.002258 |
GO:0031507 | heterochromatin formation | 2.6% (6/231) | 2.83 | 0.000217 | 0.002302 |
GO:0007049 | cell cycle | 5.19% (12/231) | 1.79 | 0.000221 | 0.002325 |
GO:0030030 | cell projection organization | 4.33% (10/231) | 2.01 | 0.00022 | 0.002328 |
GO:0009968 | negative regulation of signal transduction | 8.23% (19/231) | 1.34 | 0.000222 | 0.002334 |
GO:0030425 | dendrite | 3.03% (7/231) | 2.54 | 0.000226 | 0.002355 |
GO:0070828 | heterochromatin organization | 2.6% (6/231) | 2.82 | 0.000226 | 0.00236 |
GO:0007093 | mitotic cell cycle checkpoint signaling | 2.6% (6/231) | 2.82 | 0.000226 | 0.00236 |
GO:0090068 | positive regulation of cell cycle process | 3.46% (8/231) | 2.32 | 0.000232 | 0.002417 |
GO:0051240 | positive regulation of multicellular organismal process | 7.36% (17/231) | 1.42 | 0.000241 | 0.002492 |
GO:0003006 | developmental process involved in reproduction | 22.94% (53/231) | 0.69 | 0.000241 | 0.002497 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 1.3% (3/231) | 4.6 | 0.00025 | 0.00258 |
GO:0072344 | rescue of stalled ribosome | 1.3% (3/231) | 4.6 | 0.00025 | 0.00258 |
GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 2.16% (5/231) | 3.15 | 0.00026 | 0.002667 |
GO:0032204 | regulation of telomere maintenance | 2.16% (5/231) | 3.14 | 0.000273 | 0.002786 |
GO:0046578 | regulation of Ras protein signal transduction | 2.16% (5/231) | 3.14 | 0.000273 | 0.002786 |
GO:0006378 | mRNA polyadenylation | 1.73% (4/231) | 3.67 | 0.000277 | 0.002828 |
GO:0010646 | regulation of cell communication | 14.72% (34/231) | 0.91 | 0.000286 | 0.00291 |
GO:0017056 | structural constituent of nuclear pore | 1.3% (3/231) | 4.53 | 0.000289 | 0.002923 |
GO:0048146 | positive regulation of fibroblast proliferation | 1.3% (3/231) | 4.53 | 0.000289 | 0.002923 |
GO:0070301 | cellular response to hydrogen peroxide | 2.16% (5/231) | 3.11 | 0.0003 | 0.003021 |
GO:0032446 | protein modification by small protein conjugation | 7.36% (17/231) | 1.4 | 0.000301 | 0.003024 |
GO:0009056 | catabolic process | 15.58% (36/231) | 0.87 | 0.000299 | 0.003024 |
GO:0065008 | regulation of biological quality | 19.48% (45/231) | 0.75 | 0.000304 | 0.003045 |
GO:0009966 | regulation of signal transduction | 13.85% (32/231) | 0.94 | 0.000309 | 0.00309 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 2.16% (5/231) | 3.1 | 0.000314 | 0.003136 |
GO:0140223 | general transcription initiation factor activity | 1.73% (4/231) | 3.62 | 0.00032 | 0.003184 |
GO:0043433 | negative regulation of DNA-binding transcription factor activity | 2.16% (5/231) | 3.08 | 0.000329 | 0.003269 |
GO:0007611 | learning or memory | 2.6% (6/231) | 2.71 | 0.000335 | 0.003319 |
GO:0045202 | synapse | 4.76% (11/231) | 1.82 | 0.000338 | 0.003331 |
GO:0051960 | regulation of nervous system development | 3.03% (7/231) | 2.44 | 0.000337 | 0.003334 |
GO:0007292 | female gamete generation | 2.16% (5/231) | 3.07 | 0.000345 | 0.003342 |
GO:0101005 | deubiquitinase activity | 2.16% (5/231) | 3.07 | 0.000345 | 0.003342 |
GO:0010718 | positive regulation of epithelial to mesenchymal transition | 0.87% (2/231) | 6.08 | 0.000344 | 0.003347 |
GO:0000268 | peroxisome targeting sequence binding | 0.87% (2/231) | 6.08 | 0.000344 | 0.003347 |
GO:0042868 | antisense RNA metabolic process | 0.87% (2/231) | 6.08 | 0.000344 | 0.003347 |
GO:0120290 | stalled replication fork localization to nuclear periphery | 0.87% (2/231) | 6.08 | 0.000344 | 0.003347 |
GO:0045859 | regulation of protein kinase activity | 3.46% (8/231) | 2.23 | 0.000341 | 0.003349 |
GO:0005657 | replication fork | 1.73% (4/231) | 3.57 | 0.000367 | 0.003551 |
GO:0031010 | ISWI-type complex | 1.3% (3/231) | 4.4 | 0.000376 | 0.003612 |
GO:0070829 | obsolete heterochromatin maintenance | 1.3% (3/231) | 4.4 | 0.000376 | 0.003612 |
GO:0110156 | methylguanosine-cap decapping | 1.3% (3/231) | 4.4 | 0.000376 | 0.003612 |
GO:0051054 | positive regulation of DNA metabolic process | 3.03% (7/231) | 2.41 | 0.000387 | 0.003704 |
GO:0045292 | mRNA cis splicing, via spliceosome | 1.73% (4/231) | 3.54 | 0.000393 | 0.003752 |
GO:0030029 | actin filament-based process | 3.03% (7/231) | 2.4 | 0.000397 | 0.003769 |
GO:0007283 | spermatogenesis | 3.03% (7/231) | 2.4 | 0.000397 | 0.003769 |
GO:0070918 | small regulatory ncRNA processing | 2.6% (6/231) | 2.67 | 0.000397 | 0.003784 |
GO:0030490 | maturation of SSU-rRNA | 2.16% (5/231) | 3.01 | 0.000412 | 0.003878 |
GO:0030880 | RNA polymerase complex | 2.16% (5/231) | 3.01 | 0.000412 | 0.003878 |
GO:0042254 | ribosome biogenesis | 2.16% (5/231) | 3.01 | 0.000412 | 0.003878 |
GO:1901989 | positive regulation of cell cycle phase transition | 2.6% (6/231) | 2.66 | 0.00041 | 0.003885 |
GO:0043596 | nuclear replication fork | 1.3% (3/231) | 4.34 | 0.000426 | 0.003993 |
GO:0007610 | behavior | 3.9% (9/231) | 2.02 | 0.000427 | 0.004001 |
GO:0045807 | positive regulation of endocytosis | 2.16% (5/231) | 3.0 | 0.000431 | 0.004014 |
GO:0045727 | positive regulation of translation | 3.03% (7/231) | 2.38 | 0.00043 | 0.004016 |
GO:0016192 | vesicle-mediated transport | 6.93% (16/231) | 1.4 | 0.000444 | 0.004119 |
GO:0051129 | negative regulation of cellular component organization | 4.33% (10/231) | 1.88 | 0.000443 | 0.00412 |
GO:1902105 | regulation of leukocyte differentiation | 1.73% (4/231) | 3.5 | 0.000447 | 0.004138 |
GO:2000026 | regulation of multicellular organismal development | 11.26% (26/231) | 1.03 | 0.000452 | 0.004173 |
GO:0050890 | cognition | 2.6% (6/231) | 2.62 | 0.000467 | 0.004305 |
GO:0005634 | nucleus | 22.51% (52/231) | 0.66 | 0.000469 | 0.004308 |
GO:0042981 | regulation of apoptotic process | 5.63% (13/231) | 1.58 | 0.000472 | 0.004326 |
GO:0097485 | neuron projection guidance | 1.73% (4/231) | 3.47 | 0.000476 | 0.004359 |
GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic | 1.3% (3/231) | 4.29 | 0.000479 | 0.004365 |
GO:0110154 | RNA decapping | 1.3% (3/231) | 4.29 | 0.000479 | 0.004365 |
GO:0140030 | modification-dependent protein binding | 2.6% (6/231) | 2.6 | 0.000498 | 0.004527 |
GO:0035861 | site of double-strand break | 1.73% (4/231) | 3.45 | 0.000507 | 0.004597 |
GO:0070878 | primary miRNA binding | 0.87% (2/231) | 5.82 | 0.000514 | 0.004607 |
GO:1900369 | negative regulation of post-transcriptional gene silencing by RNA | 0.87% (2/231) | 5.82 | 0.000514 | 0.004607 |
GO:0097240 | chromosome attachment to the nuclear envelope | 0.87% (2/231) | 5.82 | 0.000514 | 0.004607 |
GO:0070478 | nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay | 0.87% (2/231) | 5.82 | 0.000514 | 0.004607 |
GO:0070530 | K63-linked polyubiquitin modification-dependent protein binding | 0.87% (2/231) | 5.82 | 0.000514 | 0.004607 |
GO:0023051 | regulation of signaling | 14.29% (33/231) | 0.88 | 0.000528 | 0.004722 |
GO:0007010 | cytoskeleton organization | 6.06% (14/231) | 1.49 | 0.000531 | 0.00474 |
GO:2001252 | positive regulation of chromosome organization | 2.16% (5/231) | 2.93 | 0.000532 | 0.004741 |
GO:0060999 | positive regulation of dendritic spine development | 1.3% (3/231) | 4.23 | 0.000537 | 0.004752 |
GO:2000232 | regulation of rRNA processing | 1.3% (3/231) | 4.23 | 0.000537 | 0.004752 |
GO:0048025 | negative regulation of mRNA splicing, via spliceosome | 1.3% (3/231) | 4.23 | 0.000537 | 0.004752 |
GO:0032268 | regulation of cellular protein metabolic process | 1.73% (4/231) | 3.43 | 0.000539 | 0.004759 |
GO:0016887 | ATP hydrolysis activity | 2.16% (5/231) | 2.92 | 0.000554 | 0.004886 |
GO:0010975 | regulation of neuron projection development | 3.03% (7/231) | 2.32 | 0.00057 | 0.005012 |
GO:0001934 | positive regulation of protein phosphorylation | 3.03% (7/231) | 2.31 | 0.000584 | 0.005126 |
GO:0030874 | nucleolar chromatin | 1.3% (3/231) | 4.18 | 0.000598 | 0.005231 |
GO:0071027 | nuclear RNA surveillance | 1.3% (3/231) | 4.18 | 0.000598 | 0.005231 |
GO:0120035 | regulation of plasma membrane bounded cell projection organization | 3.46% (8/231) | 2.11 | 0.000602 | 0.005252 |
GO:0000792 | heterochromatin | 2.16% (5/231) | 2.88 | 0.000625 | 0.00544 |
GO:0017069 | snRNA binding | 1.73% (4/231) | 3.36 | 0.000643 | 0.00556 |
GO:2000757 | negative regulation of peptidyl-lysine acetylation | 1.73% (4/231) | 3.36 | 0.000643 | 0.00556 |
GO:0051656 | establishment of organelle localization | 3.9% (9/231) | 1.94 | 0.000642 | 0.00558 |
GO:0001701 | in utero embryonic development | 2.16% (5/231) | 2.87 | 0.00065 | 0.005611 |
GO:0010562 | positive regulation of phosphorus metabolic process | 3.46% (8/231) | 2.09 | 0.000667 | 0.005723 |
GO:0045937 | positive regulation of phosphate metabolic process | 3.46% (8/231) | 2.09 | 0.000667 | 0.005723 |
GO:1902555 | endoribonuclease complex | 1.3% (3/231) | 4.13 | 0.000665 | 0.005724 |
GO:0031491 | nucleosome binding | 1.73% (4/231) | 3.34 | 0.00068 | 0.0058 |
GO:0008173 | RNA methyltransferase activity | 1.73% (4/231) | 3.34 | 0.00068 | 0.0058 |
GO:1901701 | cellular response to oxygen-containing compound | 8.23% (19/231) | 1.21 | 0.000679 | 0.005809 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 2.6% (6/231) | 2.5 | 0.000717 | 0.006021 |
GO:0060967 | negative regulation of gene silencing by RNA | 0.87% (2/231) | 5.6 | 0.000716 | 0.006029 |
GO:0042789 | mRNA transcription by RNA polymerase II | 0.87% (2/231) | 5.6 | 0.000716 | 0.006029 |
GO:0030237 | female sex determination | 0.87% (2/231) | 5.6 | 0.000716 | 0.006029 |
GO:0036396 | RNA N6-methyladenosine methyltransferase complex | 0.87% (2/231) | 5.6 | 0.000716 | 0.006029 |
GO:0031080 | nuclear pore outer ring | 0.87% (2/231) | 5.6 | 0.000716 | 0.006029 |
GO:0070742 | C2H2 zinc finger domain binding | 0.87% (2/231) | 5.6 | 0.000716 | 0.006029 |
GO:0034502 | protein localization to chromosome | 1.73% (4/231) | 3.32 | 0.00072 | 0.006034 |
GO:1905348 | endonuclease complex | 1.3% (3/231) | 4.08 | 0.000735 | 0.006139 |
GO:0010520 | regulation of reciprocal meiotic recombination | 1.3% (3/231) | 4.08 | 0.000735 | 0.006139 |
GO:0050790 | regulation of catalytic activity | 7.79% (18/231) | 1.24 | 0.000738 | 0.006148 |
GO:0031344 | regulation of cell projection organization | 3.46% (8/231) | 2.06 | 0.000753 | 0.00626 |
GO:0051493 | regulation of cytoskeleton organization | 3.46% (8/231) | 2.05 | 0.000783 | 0.0065 |
GO:0031401 | positive regulation of protein modification process | 4.76% (11/231) | 1.67 | 0.000788 | 0.006526 |
GO:0098727 | maintenance of cell number | 4.76% (11/231) | 1.67 | 0.000799 | 0.006604 |
GO:0016584 | obsolete nucleosome positioning | 1.3% (3/231) | 4.03 | 0.00081 | 0.006658 |
GO:0071168 | protein localization to chromatin | 1.3% (3/231) | 4.03 | 0.00081 | 0.006658 |
GO:0071025 | RNA surveillance | 1.3% (3/231) | 4.03 | 0.00081 | 0.006658 |
GO:0005856 | cytoskeleton | 4.76% (11/231) | 1.66 | 0.000821 | 0.006734 |
GO:0005667 | transcription regulator complex | 3.46% (8/231) | 2.04 | 0.000831 | 0.006798 |
GO:0050793 | regulation of developmental process | 18.18% (42/231) | 0.72 | 0.000848 | 0.006902 |
GO:0030371 | translation repressor activity | 1.73% (4/231) | 3.25 | 0.000847 | 0.006902 |
GO:0036002 | pre-mRNA binding | 1.73% (4/231) | 3.25 | 0.000847 | 0.006902 |
GO:2001020 | regulation of response to DNA damage stimulus | 3.03% (7/231) | 2.22 | 0.000854 | 0.006933 |
GO:0061659 | ubiquitin-like protein ligase activity | 3.9% (9/231) | 1.88 | 0.000863 | 0.006994 |
GO:0040028 | regulation of vulval development | 1.3% (3/231) | 3.99 | 0.00089 | 0.007158 |
GO:0007338 | single fertilization | 1.3% (3/231) | 3.99 | 0.00089 | 0.007158 |
GO:0009299 | mRNA transcription | 1.3% (3/231) | 3.99 | 0.00089 | 0.007158 |
GO:0050686 | negative regulation of mRNA processing | 1.3% (3/231) | 3.99 | 0.00089 | 0.007158 |
GO:0006310 | DNA recombination | 3.03% (7/231) | 2.2 | 0.000894 | 0.00717 |
GO:0050767 | regulation of neurogenesis | 2.6% (6/231) | 2.44 | 0.000899 | 0.007187 |
GO:0032956 | regulation of actin cytoskeleton organization | 2.6% (6/231) | 2.44 | 0.000899 | 0.007187 |
GO:0051239 | regulation of multicellular organismal process | 14.29% (33/231) | 0.83 | 0.000907 | 0.007237 |
GO:0060341 | regulation of cellular localization | 5.19% (12/231) | 1.56 | 0.000917 | 0.007301 |
GO:0045184 | establishment of protein localization | 7.36% (17/231) | 1.25 | 0.000952 | 0.007431 |
GO:0016590 | ACF complex | 0.87% (2/231) | 5.4 | 0.000951 | 0.007442 |
GO:0035186 | syncytial blastoderm mitotic cell cycle | 0.87% (2/231) | 5.4 | 0.000951 | 0.007442 |
GO:0070933 | histone H4 deacetylation | 0.87% (2/231) | 5.4 | 0.000951 | 0.007442 |
GO:0055087 | Ski complex | 0.87% (2/231) | 5.4 | 0.000951 | 0.007442 |
GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity | 0.87% (2/231) | 5.4 | 0.000951 | 0.007442 |
GO:0044773 | mitotic DNA damage checkpoint signaling | 1.73% (4/231) | 3.21 | 0.00094 | 0.007468 |
GO:0019783 | ubiquitin-like protein peptidase activity | 2.16% (5/231) | 2.75 | 0.000944 | 0.007484 |
GO:0031056 | regulation of histone modification | 3.46% (8/231) | 2.01 | 0.00095 | 0.007508 |
GO:0006997 | nucleus organization | 2.6% (6/231) | 2.43 | 0.00095 | 0.00752 |
GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 2.16% (5/231) | 2.74 | 0.000978 | 0.007621 |
GO:0006469 | negative regulation of protein kinase activity | 1.73% (4/231) | 3.19 | 0.000989 | 0.007695 |
GO:1901984 | negative regulation of protein acetylation | 1.73% (4/231) | 3.17 | 0.00104 | 0.008076 |
GO:1901575 | organic substance catabolic process | 13.42% (31/231) | 0.85 | 0.001051 | 0.008145 |
GO:0098787 | mRNA cleavage involved in mRNA processing | 1.3% (3/231) | 3.9 | 0.001065 | 0.008206 |
GO:0098789 | pre-mRNA cleavage required for polyadenylation | 1.3% (3/231) | 3.9 | 0.001065 | 0.008206 |
GO:0048145 | regulation of fibroblast proliferation | 1.3% (3/231) | 3.9 | 0.001065 | 0.008206 |
GO:0042393 | histone binding | 3.03% (7/231) | 2.15 | 0.001091 | 0.008327 |
GO:0042327 | positive regulation of phosphorylation | 3.03% (7/231) | 2.15 | 0.001091 | 0.008327 |
GO:1902373 | negative regulation of mRNA catabolic process | 1.73% (4/231) | 3.15 | 0.001093 | 0.008328 |
GO:0003008 | system process | 5.19% (12/231) | 1.53 | 0.001088 | 0.008338 |
GO:0009756 | carbohydrate mediated signaling | 2.6% (6/231) | 2.39 | 0.001087 | 0.008344 |
GO:0010182 | sugar mediated signaling pathway | 2.6% (6/231) | 2.39 | 0.001087 | 0.008344 |
GO:0060966 | regulation of gene silencing by RNA | 1.73% (4/231) | 3.14 | 0.001147 | 0.008695 |
GO:0071824 | protein-DNA complex subunit organization | 2.6% (6/231) | 2.37 | 0.001146 | 0.008697 |
GO:0043009 | chordate embryonic development | 2.6% (6/231) | 2.37 | 0.001146 | 0.008697 |
GO:0071705 | nitrogen compound transport | 9.96% (23/231) | 1.01 | 0.001219 | 0.009105 |
GO:0090734 | site of DNA damage | 1.73% (4/231) | 3.12 | 0.001204 | 0.009106 |
GO:0070883 | pre-miRNA binding | 0.87% (2/231) | 5.23 | 0.001218 | 0.009114 |
GO:0031213 | RSF complex | 0.87% (2/231) | 5.23 | 0.001218 | 0.009114 |
GO:0033301 | cell cycle comprising mitosis without cytokinesis | 0.87% (2/231) | 5.23 | 0.001218 | 0.009114 |
GO:0045448 | mitotic cell cycle, embryonic | 0.87% (2/231) | 5.23 | 0.001218 | 0.009114 |
GO:0031379 | RNA-directed RNA polymerase complex | 0.87% (2/231) | 5.23 | 0.001218 | 0.009114 |
GO:0005731 | nucleolus organizer region | 0.87% (2/231) | 5.23 | 0.001218 | 0.009114 |
GO:1901992 | positive regulation of mitotic cell cycle phase transition | 2.16% (5/231) | 2.66 | 0.001242 | 0.009258 |
GO:0042800 | histone methyltransferase activity (H3-K4 specific) | 1.3% (3/231) | 3.82 | 0.00126 | 0.009372 |
GO:1902533 | positive regulation of intracellular signal transduction | 3.9% (9/231) | 1.8 | 0.001276 | 0.009461 |
GO:0071310 | cellular response to organic substance | 8.66% (20/231) | 1.09 | 0.001276 | 0.009474 |
GO:0016441 | post-transcriptional gene silencing | 2.16% (5/231) | 2.65 | 0.001284 | 0.0095 |
GO:0015031 | protein transport | 6.93% (16/231) | 1.25 | 0.001305 | 0.009643 |
GO:0051983 | regulation of chromosome segregation | 2.16% (5/231) | 2.64 | 0.001326 | 0.009763 |
GO:0034614 | cellular response to reactive oxygen species | 2.16% (5/231) | 2.64 | 0.001326 | 0.009763 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2.6% (6/231) | 2.32 | 0.00137 | 0.010033 |
GO:0098978 | glutamatergic synapse | 2.6% (6/231) | 2.32 | 0.00137 | 0.010033 |
GO:0032970 | regulation of actin filament-based process | 2.6% (6/231) | 2.32 | 0.00137 | 0.010033 |
GO:0035264 | multicellular organism growth | 1.73% (4/231) | 3.06 | 0.001385 | 0.010121 |
GO:0042752 | regulation of circadian rhythm | 2.6% (6/231) | 2.32 | 0.001405 | 0.010232 |
GO:0060284 | regulation of cell development | 3.03% (7/231) | 2.09 | 0.001405 | 0.010249 |
GO:0030054 | cell junction | 15.58% (36/231) | 0.75 | 0.001422 | 0.010338 |
GO:0001510 | RNA methylation | 1.73% (4/231) | 3.05 | 0.001449 | 0.010516 |
GO:0019900 | kinase binding | 5.63% (13/231) | 1.4 | 0.001456 | 0.010544 |
GO:0043144 | sno(s)RNA processing | 1.3% (3/231) | 3.74 | 0.001475 | 0.010649 |
GO:0060148 | positive regulation of post-transcriptional gene silencing | 1.3% (3/231) | 3.74 | 0.001475 | 0.010649 |
GO:0032241 | positive regulation of nucleobase-containing compound transport | 0.87% (2/231) | 5.08 | 0.001517 | 0.010722 |
GO:0035983 | response to trichostatin A | 0.87% (2/231) | 5.08 | 0.001517 | 0.010722 |
GO:0035984 | cellular response to trichostatin A | 0.87% (2/231) | 5.08 | 0.001517 | 0.010722 |
GO:0071047 | polyadenylation-dependent mRNA catabolic process | 0.87% (2/231) | 5.08 | 0.001517 | 0.010722 |
GO:0050265 | RNA uridylyltransferase activity | 0.87% (2/231) | 5.08 | 0.001517 | 0.010722 |
GO:0070920 | regulation of production of small RNA involved in gene silencing by RNA | 0.87% (2/231) | 5.08 | 0.001517 | 0.010722 |
GO:0033549 | MAP kinase phosphatase activity | 0.87% (2/231) | 5.08 | 0.001517 | 0.010722 |
GO:0051093 | negative regulation of developmental process | 6.93% (16/231) | 1.23 | 0.001491 | 0.010746 |
GO:0051099 | positive regulation of binding | 2.16% (5/231) | 2.6 | 0.001508 | 0.010825 |
GO:0033674 | positive regulation of kinase activity | 2.16% (5/231) | 2.6 | 0.001508 | 0.010825 |
GO:0047485 | protein N-terminus binding | 1.73% (4/231) | 3.03 | 0.001516 | 0.010845 |
GO:0033673 | negative regulation of kinase activity | 1.73% (4/231) | 3.03 | 0.001516 | 0.010845 |
GO:0014013 | regulation of gliogenesis | 1.3% (3/231) | 3.7 | 0.001591 | 0.011153 |
GO:0042273 | ribosomal large subunit biogenesis | 1.3% (3/231) | 3.7 | 0.001591 | 0.011153 |
GO:0031032 | actomyosin structure organization | 1.3% (3/231) | 3.7 | 0.001591 | 0.011153 |
GO:0005669 | transcription factor TFIID complex | 1.3% (3/231) | 3.7 | 0.001591 | 0.011153 |
GO:0016251 | RNA polymerase II general transcription initiation factor activity | 1.3% (3/231) | 3.7 | 0.001591 | 0.011153 |
GO:0006508 | proteolysis | 7.79% (18/231) | 1.14 | 0.001602 | 0.011206 |
GO:0045892 | negative regulation of DNA-templated transcription | 7.36% (17/231) | 1.17 | 0.001647 | 0.011502 |
GO:0044774 | mitotic DNA integrity checkpoint signaling | 1.73% (4/231) | 2.99 | 0.001655 | 0.011518 |
GO:0061387 | regulation of extent of cell growth | 1.73% (4/231) | 2.99 | 0.001655 | 0.011518 |
GO:0032781 | positive regulation of ATP-dependent activity | 1.3% (3/231) | 3.67 | 0.001713 | 0.011863 |
GO:0033119 | negative regulation of RNA splicing | 1.3% (3/231) | 3.67 | 0.001713 | 0.011863 |
GO:0007530 | sex determination | 1.3% (3/231) | 3.67 | 0.001713 | 0.011863 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 3.46% (8/231) | 1.86 | 0.001773 | 0.01226 |
GO:1902679 | negative regulation of RNA biosynthetic process | 7.36% (17/231) | 1.16 | 0.001787 | 0.012314 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 7.36% (17/231) | 1.16 | 0.001787 | 0.012314 |
GO:0061780 | mitotic cohesin loading | 0.87% (2/231) | 4.94 | 0.001847 | 0.012452 |
GO:0071921 | cohesin loading | 0.87% (2/231) | 4.94 | 0.001847 | 0.012452 |
GO:0010717 | regulation of epithelial to mesenchymal transition | 0.87% (2/231) | 4.94 | 0.001847 | 0.012452 |
GO:0033313 | meiotic cell cycle checkpoint signaling | 0.87% (2/231) | 4.94 | 0.001847 | 0.012452 |
GO:0045293 | mRNA editing complex | 0.87% (2/231) | 4.94 | 0.001847 | 0.012452 |
GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery | 0.87% (2/231) | 4.94 | 0.001847 | 0.012452 |
GO:0000244 | spliceosomal tri-snRNP complex assembly | 0.87% (2/231) | 4.94 | 0.001847 | 0.012452 |
GO:0032480 | negative regulation of type I interferon production | 0.87% (2/231) | 4.94 | 0.001847 | 0.012452 |
GO:0098742 | cell-cell adhesion via plasma-membrane adhesion molecules | 0.87% (2/231) | 4.94 | 0.001847 | 0.012452 |
GO:0043414 | macromolecule methylation | 3.46% (8/231) | 1.85 | 0.001864 | 0.012549 |
GO:0005524 | ATP binding | 9.96% (23/231) | 0.96 | 0.001841 | 0.012604 |
GO:0034661 | ncRNA catabolic process | 1.3% (3/231) | 3.63 | 0.00184 | 0.012616 |
GO:0051896 | regulation of protein kinase B signaling | 1.3% (3/231) | 3.63 | 0.00184 | 0.012616 |
GO:0071356 | cellular response to tumor necrosis factor | 1.3% (3/231) | 3.63 | 0.00184 | 0.012616 |
GO:0008016 | regulation of heart contraction | 1.73% (4/231) | 2.94 | 0.00188 | 0.012634 |
GO:0030100 | regulation of endocytosis | 2.6% (6/231) | 2.23 | 0.00192 | 0.012881 |
GO:0043065 | positive regulation of apoptotic process | 2.6% (6/231) | 2.22 | 0.001964 | 0.01316 |
GO:0010638 | positive regulation of organelle organization | 3.46% (8/231) | 1.83 | 0.002023 | 0.013533 |
GO:0003714 | transcription corepressor activity | 2.16% (5/231) | 2.49 | 0.0021 | 0.014021 |
GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.3% (3/231) | 3.56 | 0.002112 | 0.014079 |
GO:0000209 | protein polyubiquitination | 3.03% (7/231) | 1.98 | 0.00216 | 0.014378 |
GO:0043227 | membrane-bounded organelle | 44.59% (103/231) | 0.34 | 0.002166 | 0.01439 |
GO:0032760 | positive regulation of tumor necrosis factor production | 0.87% (2/231) | 4.82 | 0.002207 | 0.014433 |
GO:0070578 | RISC-loading complex | 0.87% (2/231) | 4.82 | 0.002207 | 0.014433 |
GO:1903557 | positive regulation of tumor necrosis factor superfamily cytokine production | 0.87% (2/231) | 4.82 | 0.002207 | 0.014433 |
GO:0008623 | CHRAC | 0.87% (2/231) | 4.82 | 0.002207 | 0.014433 |
GO:0035063 | nuclear speck organization | 0.87% (2/231) | 4.82 | 0.002207 | 0.014433 |
GO:0035092 | sperm DNA condensation | 0.87% (2/231) | 4.82 | 0.002207 | 0.014433 |
GO:0022612 | gland morphogenesis | 0.87% (2/231) | 4.82 | 0.002207 | 0.014433 |
GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' | 0.87% (2/231) | 4.82 | 0.002207 | 0.014433 |
GO:0016427 | tRNA (cytosine) methyltransferase activity | 0.87% (2/231) | 4.82 | 0.002207 | 0.014433 |
GO:0000019 | regulation of mitotic recombination | 0.87% (2/231) | 4.82 | 0.002207 | 0.014433 |
GO:0048477 | oogenesis | 1.73% (4/231) | 2.88 | 0.002211 | 0.014437 |
GO:0007549 | dosage compensation | 1.3% (3/231) | 3.53 | 0.002257 | 0.014547 |
GO:0060261 | positive regulation of transcription initiation by RNA polymerase II | 1.3% (3/231) | 3.53 | 0.002257 | 0.014547 |
GO:1901532 | regulation of hematopoietic progenitor cell differentiation | 1.3% (3/231) | 3.53 | 0.002257 | 0.014547 |
GO:0071222 | cellular response to lipopolysaccharide | 1.3% (3/231) | 3.53 | 0.002257 | 0.014547 |
GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 1.3% (3/231) | 3.53 | 0.002257 | 0.014547 |
GO:0031514 | motile cilium | 1.3% (3/231) | 3.53 | 0.002257 | 0.014547 |
GO:0002064 | epithelial cell development | 1.3% (3/231) | 3.53 | 0.002257 | 0.014547 |
GO:0010941 | regulation of cell death | 7.36% (17/231) | 1.13 | 0.002252 | 0.014677 |
GO:0007155 | cell adhesion | 2.16% (5/231) | 2.46 | 0.002287 | 0.014697 |
GO:0045995 | regulation of embryonic development | 2.16% (5/231) | 2.46 | 0.002287 | 0.014697 |
GO:1903522 | regulation of blood circulation | 1.73% (4/231) | 2.86 | 0.0023 | 0.014735 |
GO:0050000 | chromosome localization | 1.73% (4/231) | 2.86 | 0.0023 | 0.014735 |
GO:0051050 | positive regulation of transport | 4.33% (10/231) | 1.56 | 0.002329 | 0.014899 |
GO:0060759 | regulation of response to cytokine stimulus | 1.3% (3/231) | 3.5 | 0.002407 | 0.015374 |
GO:0010228 | vegetative to reproductive phase transition of meristem | 3.03% (7/231) | 1.95 | 0.002413 | 0.015383 |
GO:0019827 | stem cell population maintenance | 4.33% (10/231) | 1.55 | 0.002479 | 0.015782 |
GO:0035639 | purine ribonucleoside triphosphate binding | 10.82% (25/231) | 0.88 | 0.002503 | 0.015884 |
GO:0051098 | regulation of binding | 3.03% (7/231) | 1.94 | 0.002501 | 0.015901 |
GO:0035098 | ESC/E(Z) complex | 0.87% (2/231) | 4.7 | 0.002598 | 0.016215 |
GO:0000992 | RNA polymerase III cis-regulatory region sequence-specific DNA binding | 0.87% (2/231) | 4.7 | 0.002598 | 0.016215 |
GO:0031573 | mitotic intra-S DNA damage checkpoint signaling | 0.87% (2/231) | 4.7 | 0.002598 | 0.016215 |
GO:0045429 | positive regulation of nitric oxide biosynthetic process | 0.87% (2/231) | 4.7 | 0.002598 | 0.016215 |
GO:1904407 | positive regulation of nitric oxide metabolic process | 0.87% (2/231) | 4.7 | 0.002598 | 0.016215 |
GO:0070932 | histone H3 deacetylation | 0.87% (2/231) | 4.7 | 0.002598 | 0.016215 |
GO:0010172 | embryonic body morphogenesis | 0.87% (2/231) | 4.7 | 0.002598 | 0.016215 |
GO:0010220 | positive regulation of vernalization response | 0.87% (2/231) | 4.7 | 0.002598 | 0.016215 |
GO:1990935 | splicing factor binding | 0.87% (2/231) | 4.7 | 0.002598 | 0.016215 |
GO:0000915 | actomyosin contractile ring assembly | 0.87% (2/231) | 4.7 | 0.002598 | 0.016215 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 3.46% (8/231) | 1.77 | 0.002606 | 0.016241 |
GO:2000144 | positive regulation of DNA-templated transcription initiation | 1.3% (3/231) | 3.46 | 0.002564 | 0.016249 |
GO:0031060 | regulation of histone methylation | 2.6% (6/231) | 2.14 | 0.002621 | 0.016309 |
GO:0018024 | histone-lysine N-methyltransferase activity | 1.73% (4/231) | 2.8 | 0.00268 | 0.016624 |
GO:0097367 | carbohydrate derivative binding | 12.12% (28/231) | 0.81 | 0.002678 | 0.016636 |
GO:0010212 | response to ionizing radiation | 2.16% (5/231) | 2.4 | 0.002698 | 0.016708 |
GO:0030866 | cortical actin cytoskeleton organization | 1.3% (3/231) | 3.43 | 0.002727 | 0.016865 |
GO:0035065 | regulation of histone acetylation | 1.73% (4/231) | 2.79 | 0.002781 | 0.017174 |
GO:0034599 | cellular response to oxidative stress | 2.6% (6/231) | 2.11 | 0.002853 | 0.017591 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 3.03% (7/231) | 1.91 | 0.002883 | 0.017747 |
GO:0006376 | mRNA splice site selection | 1.3% (3/231) | 3.4 | 0.002896 | 0.017804 |
GO:0000805 | X chromosome | 0.87% (2/231) | 4.6 | 0.00302 | 0.018424 |
GO:0034458 | 3'-5' RNA helicase activity | 0.87% (2/231) | 4.6 | 0.00302 | 0.018424 |
GO:0042287 | MHC protein binding | 0.87% (2/231) | 4.6 | 0.00302 | 0.018424 |
GO:0017151 | DEAD/H-box RNA helicase binding | 0.87% (2/231) | 4.6 | 0.00302 | 0.018424 |
GO:0044837 | actomyosin contractile ring organization | 0.87% (2/231) | 4.6 | 0.00302 | 0.018424 |
GO:0061630 | ubiquitin protein ligase activity | 3.46% (8/231) | 1.74 | 0.003033 | 0.018476 |
GO:0099175 | regulation of postsynapse organization | 1.3% (3/231) | 3.37 | 0.003072 | 0.018687 |
GO:0006302 | double-strand break repair | 2.6% (6/231) | 2.09 | 0.0031 | 0.01883 |
GO:0030036 | actin cytoskeleton organization | 2.16% (5/231) | 2.35 | 0.003159 | 0.019134 |
GO:0007165 | signal transduction | 16.45% (38/231) | 0.66 | 0.003159 | 0.019162 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 1.73% (4/231) | 2.73 | 0.003213 | 0.019428 |
GO:0008143 | poly(A) binding | 1.3% (3/231) | 3.34 | 0.003254 | 0.019619 |
GO:0098609 | cell-cell adhesion | 1.3% (3/231) | 3.34 | 0.003254 | 0.019619 |
GO:0045595 | regulation of cell differentiation | 5.63% (13/231) | 1.27 | 0.003336 | 0.020082 |
GO:0048585 | negative regulation of response to stimulus | 10.39% (24/231) | 0.87 | 0.003355 | 0.020172 |
GO:0002009 | morphogenesis of an epithelium | 2.16% (5/231) | 2.32 | 0.00341 | 0.020443 |
GO:0045931 | positive regulation of mitotic cell cycle | 2.16% (5/231) | 2.32 | 0.00341 | 0.020443 |
GO:0090257 | regulation of muscle system process | 1.73% (4/231) | 2.7 | 0.003445 | 0.020557 |
GO:0099023 | vesicle tethering complex | 1.73% (4/231) | 2.7 | 0.003445 | 0.020557 |
GO:0060260 | regulation of transcription initiation by RNA polymerase II | 1.3% (3/231) | 3.32 | 0.003442 | 0.020604 |
GO:0048714 | positive regulation of oligodendrocyte differentiation | 0.87% (2/231) | 4.5 | 0.003471 | 0.020623 |
GO:0002031 | G protein-coupled receptor internalization | 0.87% (2/231) | 4.5 | 0.003471 | 0.020623 |
GO:0071598 | neuronal ribonucleoprotein granule | 0.87% (2/231) | 4.5 | 0.003471 | 0.020623 |
GO:1903320 | regulation of protein modification by small protein conjugation or removal | 2.6% (6/231) | 2.05 | 0.0035 | 0.020766 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 3.9% (9/231) | 1.58 | 0.003537 | 0.020956 |
GO:0000469 | cleavage involved in rRNA processing | 1.73% (4/231) | 2.69 | 0.003565 | 0.021089 |
GO:0031330 | negative regulation of cellular catabolic process | 2.6% (6/231) | 2.05 | 0.00357 | 0.021091 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 3.9% (9/231) | 1.58 | 0.003582 | 0.021134 |
GO:0048285 | organelle fission | 2.6% (6/231) | 2.04 | 0.003641 | 0.02142 |
GO:0043628 | small regulatory ncRNA 3'-end processing | 1.3% (3/231) | 3.29 | 0.003637 | 0.021427 |
GO:0051234 | establishment of localization | 17.75% (41/231) | 0.61 | 0.003703 | 0.021753 |
GO:0001221 | transcription coregulator binding | 1.3% (3/231) | 3.26 | 0.003839 | 0.022517 |
GO:1903842 | response to arsenite ion | 0.87% (2/231) | 4.4 | 0.003951 | 0.022913 |
GO:1903843 | cellular response to arsenite ion | 0.87% (2/231) | 4.4 | 0.003951 | 0.022913 |
GO:0000349 | generation of catalytic spliceosome for first transesterification step | 0.87% (2/231) | 4.4 | 0.003951 | 0.022913 |
GO:0001016 | RNA polymerase III transcription regulatory region sequence-specific DNA binding | 0.87% (2/231) | 4.4 | 0.003951 | 0.022913 |
GO:0007569 | obsolete cell aging | 0.87% (2/231) | 4.4 | 0.003951 | 0.022913 |
GO:0045835 | negative regulation of meiotic nuclear division | 0.87% (2/231) | 4.4 | 0.003951 | 0.022913 |
GO:0010171 | body morphogenesis | 0.87% (2/231) | 4.4 | 0.003951 | 0.022913 |
GO:0006886 | intracellular protein transport | 5.19% (12/231) | 1.3 | 0.003975 | 0.023016 |
GO:0051094 | positive regulation of developmental process | 7.36% (17/231) | 1.05 | 0.003942 | 0.023088 |
GO:0032479 | regulation of type I interferon production | 1.3% (3/231) | 3.23 | 0.004047 | 0.023371 |
GO:0044030 | regulation of DNA methylation | 1.3% (3/231) | 3.23 | 0.004047 | 0.023371 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 1.73% (4/231) | 2.63 | 0.004073 | 0.023391 |
GO:0016278 | lysine N-methyltransferase activity | 1.73% (4/231) | 2.63 | 0.004073 | 0.023391 |
GO:0016279 | protein-lysine N-methyltransferase activity | 1.73% (4/231) | 2.63 | 0.004073 | 0.023391 |
GO:0031334 | positive regulation of protein-containing complex assembly | 1.73% (4/231) | 2.63 | 0.004073 | 0.023391 |
GO:0016787 | hydrolase activity | 16.02% (37/231) | 0.64 | 0.004189 | 0.024019 |
GO:0061980 | regulatory RNA binding | 1.3% (3/231) | 3.21 | 0.004262 | 0.024305 |
GO:0007411 | axon guidance | 1.3% (3/231) | 3.21 | 0.004262 | 0.024305 |
GO:0034063 | stress granule assembly | 1.3% (3/231) | 3.21 | 0.004262 | 0.024305 |
GO:0001818 | negative regulation of cytokine production | 1.3% (3/231) | 3.21 | 0.004262 | 0.024305 |
GO:0045120 | pronucleus | 0.87% (2/231) | 4.32 | 0.004461 | 0.025191 |
GO:0046976 | histone methyltransferase activity (H3-K27 specific) | 0.87% (2/231) | 4.32 | 0.004461 | 0.025191 |
GO:0030838 | positive regulation of actin filament polymerization | 0.87% (2/231) | 4.32 | 0.004461 | 0.025191 |
GO:0035023 | regulation of Rho protein signal transduction | 0.87% (2/231) | 4.32 | 0.004461 | 0.025191 |
GO:0062176 | R-loop disassembly | 0.87% (2/231) | 4.32 | 0.004461 | 0.025191 |
GO:0010001 | glial cell differentiation | 0.87% (2/231) | 4.32 | 0.004461 | 0.025191 |
GO:0000395 | mRNA 5'-splice site recognition | 0.87% (2/231) | 4.32 | 0.004461 | 0.025191 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3.9% (9/231) | 1.52 | 0.004535 | 0.025577 |
GO:0061024 | membrane organization | 4.33% (10/231) | 1.42 | 0.00459 | 0.02585 |
GO:0000278 | mitotic cell cycle | 1.73% (4/231) | 2.58 | 0.004629 | 0.025999 |
GO:1901983 | regulation of protein acetylation | 1.73% (4/231) | 2.58 | 0.004629 | 0.025999 |
GO:0032559 | adenyl ribonucleotide binding | 9.96% (23/231) | 0.85 | 0.004642 | 0.026034 |
GO:1901214 | regulation of neuron death | 2.16% (5/231) | 2.22 | 0.004666 | 0.026134 |
GO:0006366 | transcription by RNA polymerase II | 1.3% (3/231) | 3.15 | 0.004713 | 0.026254 |
GO:0051568 | histone H3-K4 methylation | 1.3% (3/231) | 3.15 | 0.004713 | 0.026254 |
GO:0034612 | response to tumor necrosis factor | 1.3% (3/231) | 3.15 | 0.004713 | 0.026254 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 4.76% (11/231) | 1.34 | 0.004701 | 0.026297 |
GO:0033045 | regulation of sister chromatid segregation | 1.73% (4/231) | 2.57 | 0.004776 | 0.026567 |
GO:0032553 | ribonucleotide binding | 11.26% (26/231) | 0.79 | 0.004797 | 0.026616 |
GO:0140694 | non-membrane-bounded organelle assembly | 3.03% (7/231) | 1.77 | 0.004795 | 0.02664 |
GO:0019941 | modification-dependent protein catabolic process | 4.76% (11/231) | 1.33 | 0.004891 | 0.027101 |
GO:0010942 | positive regulation of cell death | 3.9% (9/231) | 1.5 | 0.004932 | 0.027217 |
GO:0030554 | adenyl nucleotide binding | 9.96% (23/231) | 0.85 | 0.004931 | 0.027245 |
GO:0000793 | condensed chromosome | 1.73% (4/231) | 2.56 | 0.004925 | 0.027251 |
GO:0010592 | positive regulation of lamellipodium assembly | 0.87% (2/231) | 4.23 | 0.004999 | 0.027254 |
GO:0045687 | positive regulation of glial cell differentiation | 0.87% (2/231) | 4.23 | 0.004999 | 0.027254 |
GO:0050881 | musculoskeletal movement | 0.87% (2/231) | 4.23 | 0.004999 | 0.027254 |
GO:1902745 | positive regulation of lamellipodium organization | 0.87% (2/231) | 4.23 | 0.004999 | 0.027254 |
GO:0000243 | commitment complex | 0.87% (2/231) | 4.23 | 0.004999 | 0.027254 |
GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis | 0.87% (2/231) | 4.23 | 0.004999 | 0.027254 |
GO:0001817 | regulation of cytokine production | 2.16% (5/231) | 2.19 | 0.004997 | 0.027462 |
GO:0000280 | nuclear division | 2.16% (5/231) | 2.19 | 0.004997 | 0.027462 |
GO:0043231 | intracellular membrane-bounded organelle | 43.29% (100/231) | 0.31 | 0.004995 | 0.027524 |
GO:0010639 | negative regulation of organelle organization | 2.6% (6/231) | 1.94 | 0.005112 | 0.027836 |
GO:2000142 | regulation of DNA-templated transcription initiation | 1.3% (3/231) | 3.11 | 0.005191 | 0.028116 |
GO:0016073 | snRNA metabolic process | 1.3% (3/231) | 3.11 | 0.005191 | 0.028116 |
GO:0051784 | negative regulation of nuclear division | 1.3% (3/231) | 3.11 | 0.005191 | 0.028116 |
GO:0035825 | homologous recombination | 1.3% (3/231) | 3.11 | 0.005191 | 0.028116 |
GO:1905818 | regulation of chromosome separation | 1.73% (4/231) | 2.53 | 0.005234 | 0.028272 |
GO:0042054 | histone methyltransferase activity | 1.73% (4/231) | 2.53 | 0.005234 | 0.028272 |
GO:0032661 | regulation of interleukin-18 production | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0032741 | positive regulation of interleukin-18 production | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0070269 | pyroptosis | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0046828 | regulation of RNA import into nucleus | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0046830 | positive regulation of RNA import into nucleus | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:2000199 | positive regulation of ribonucleoprotein complex localization | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:2000202 | positive regulation of ribosomal subunit export from nucleus | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:2000206 | regulation of ribosomal small subunit export from nucleus | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:2000208 | positive regulation of ribosomal small subunit export from nucleus | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0070921 | regulation of siRNA production | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1903705 | positive regulation of siRNA production | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0033315 | meiotic G2/MI DNA replication checkpoint signaling | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0044778 | meiotic DNA integrity checkpoint signaling | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0070310 | ATR-ATRIP complex | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0072371 | histone kinase activity (H2A-S121 specific) | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0110031 | negative regulation of G2/MI transition of meiotic cell cycle | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0042289 | MHC class II protein binding | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1900486 | positive regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:2001210 | regulation of isopentenyl diphosphate biosynthetic process, mevalonate pathway | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0032015 | regulation of Ran protein signal transduction | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0032017 | positive regulation of Ran protein signal transduction | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0140461 | obsolete subtelomeric heterochromatin organization | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0018276 | isopeptide cross-linking via N6-glycyl-L-lysine | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0070099 | regulation of chemokine-mediated signaling pathway | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0070100 | negative regulation of chemokine-mediated signaling pathway | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0043522 | leucine zipper domain binding | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0070669 | response to interleukin-2 | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0071352 | cellular response to interleukin-2 | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1904567 | response to wortmannin | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1904568 | cellular response to wortmannin | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0071667 | DNA/RNA hybrid binding | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1903932 | regulation of DNA primase activity | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1903934 | positive regulation of DNA primase activity | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0140469 | GCN2-mediated signaling | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0060729 | intestinal epithelial structure maintenance | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1904837 | beta-catenin-TCF complex assembly | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0045027 | DNA end binding | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0007295 | growth of a germarium-derived egg chamber | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0071426 | obsolete ribonucleoprotein complex export from nucleus | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0008419 | RNA lariat debranching enzyme activity | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0045992 | negative regulation of embryonic development | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0051469 | vesicle fusion with vacuole | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0034455 | t-UTP complex | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0007296 | vitellogenesis | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0021801 | cerebral cortex radial glia-guided migration | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0021852 | pyramidal neuron migration to cerebral cortex | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0022030 | telencephalon glial cell migration | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0030999 | linear element assembly | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0032207 | regulation of telomere maintenance via recombination | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0072695 | regulation of DNA recombination at telomere | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0140650 | radial glia-guided pyramidal neuron migration | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1990683 | DNA double-strand break attachment to nuclear envelope | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0010370 | perinucleolar chromocenter | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0061689 | tricellular tight junction | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0005052 | peroxisome matrix targeting signal-1 binding | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0017071 | intracellular cyclic nucleotide activated cation channel complex | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0103011 | mannosylfructose-phosphate synthase activity | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0051271 | obsolete negative regulation of cellular component movement | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0048671 | negative regulation of collateral sprouting | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0090557 | establishment of endothelial intestinal barrier | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0099060 | integral component of postsynaptic specialization membrane | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0099061 | integral component of postsynaptic density membrane | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0099150 | regulation of postsynaptic specialization assembly | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0099151 | regulation of postsynaptic density assembly | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0099560 | synaptic membrane adhesion | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1904889 | regulation of excitatory synapse assembly | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1905606 | regulation of presynapse assembly | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:1990619 | histone H3-K9 deacetylation | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0000128 | flocculation | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0098610 | adhesion between unicellular organisms | 0.43% (1/231) | 7.4 | 0.00591 | 0.028641 |
GO:0006353 | DNA-templated transcription termination | 1.3% (3/231) | 3.03 | 0.005962 | 0.028756 |
GO:0005776 | autophagosome | 1.3% (3/231) | 3.03 | 0.005962 | 0.028756 |
GO:0010498 | proteasomal protein catabolic process | 3.9% (9/231) | 1.46 | 0.005941 | 0.028758 |
GO:0080135 | regulation of cellular response to stress | 4.76% (11/231) | 1.31 | 0.005341 | 0.028816 |
GO:0018205 | peptidyl-lysine modification | 3.46% (8/231) | 1.57 | 0.005961 | 0.028819 |
GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 2.6% (6/231) | 1.92 | 0.005394 | 0.029025 |
GO:0032392 | DNA geometric change | 1.73% (4/231) | 2.52 | 0.005393 | 0.029054 |
GO:0000151 | ubiquitin ligase complex | 3.46% (8/231) | 1.57 | 0.006037 | 0.029086 |
GO:0002119 | nematode larval development | 1.3% (3/231) | 3.08 | 0.005441 | 0.029198 |
GO:0035067 | negative regulation of histone acetylation | 1.3% (3/231) | 3.08 | 0.005441 | 0.029198 |
GO:0032680 | regulation of tumor necrosis factor production | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:0035197 | siRNA binding | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:1903555 | regulation of tumor necrosis factor superfamily cytokine production | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:0070734 | histone H3-K27 methylation | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:0010591 | regulation of lamellipodium assembly | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:1902743 | regulation of lamellipodium organization | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:0035019 | somatic stem cell population maintenance | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:1900363 | regulation of mRNA polyadenylation | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:0010219 | regulation of vernalization response | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:0030897 | HOPS complex | 0.87% (2/231) | 4.08 | 0.00616 | 0.029297 |
GO:0050877 | nervous system process | 3.03% (7/231) | 1.7 | 0.006184 | 0.029379 |
GO:0045596 | negative regulation of cell differentiation | 2.6% (6/231) | 1.88 | 0.006202 | 0.029433 |
GO:0015629 | actin cytoskeleton | 1.73% (4/231) | 2.46 | 0.006236 | 0.029491 |
GO:0002791 | regulation of peptide secretion | 1.3% (3/231) | 3.01 | 0.006233 | 0.029508 |
GO:0090276 | regulation of peptide hormone secretion | 1.3% (3/231) | 3.01 | 0.006233 | 0.029508 |
GO:0004652 | polynucleotide adenylyltransferase activity | 0.87% (2/231) | 4.15 | 0.005565 | 0.029556 |
GO:0005705 | polytene chromosome interband | 0.87% (2/231) | 4.15 | 0.005565 | 0.029556 |
GO:0046579 | positive regulation of Ras protein signal transduction | 0.87% (2/231) | 4.15 | 0.005565 | 0.029556 |
GO:0048713 | regulation of oligodendrocyte differentiation | 0.87% (2/231) | 4.15 | 0.005565 | 0.029556 |
GO:0051057 | positive regulation of small GTPase mediated signal transduction | 0.87% (2/231) | 4.15 | 0.005565 | 0.029556 |
GO:0060968 | obsolete regulation of gene silencing | 0.87% (2/231) | 4.15 | 0.005565 | 0.029556 |
GO:0030707 | ovarian follicle cell development | 0.87% (2/231) | 4.15 | 0.005565 | 0.029556 |
GO:0001673 | male germ cell nucleus | 0.87% (2/231) | 4.15 | 0.005565 | 0.029556 |
GO:0072594 | establishment of protein localization to organelle | 3.46% (8/231) | 1.59 | 0.00559 | 0.029609 |
GO:0071345 | cellular response to cytokine stimulus | 2.6% (6/231) | 1.91 | 0.005589 | 0.029643 |
GO:0043067 | regulation of programmed cell death | 6.06% (14/231) | 1.1 | 0.006342 | 0.029958 |
GO:0007369 | gastrulation | 1.3% (3/231) | 3.06 | 0.005698 | 0.030142 |
GO:0042802 | identical protein binding | 12.55% (29/231) | 0.71 | 0.006432 | 0.030346 |
GO:0030261 | chromosome condensation | 1.3% (3/231) | 2.99 | 0.006511 | 0.030684 |
GO:0032555 | purine ribonucleotide binding | 10.82% (25/231) | 0.77 | 0.006538 | 0.030774 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 9.09% (21/231) | 0.87 | 0.005838 | 0.030846 |
GO:0043565 | sequence-specific DNA binding | 10.39% (24/231) | 0.79 | 0.006606 | 0.031063 |
GO:0030575 | nuclear body organization | 0.87% (2/231) | 4.01 | 0.006782 | 0.03156 |
GO:0045943 | positive regulation of transcription by RNA polymerase I | 0.87% (2/231) | 4.01 | 0.006782 | 0.03156 |
GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 0.87% (2/231) | 4.01 | 0.006782 | 0.03156 |
GO:1904035 | regulation of epithelial cell apoptotic process | 0.87% (2/231) | 4.01 | 0.006782 | 0.03156 |
GO:1904278 | positive regulation of wax biosynthetic process | 0.87% (2/231) | 4.01 | 0.006782 | 0.03156 |
GO:0002097 | tRNA wobble base modification | 0.87% (2/231) | 4.01 | 0.006782 | 0.03156 |
GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation | 0.87% (2/231) | 4.01 | 0.006782 | 0.03156 |
GO:0034472 | snRNA 3'-end processing | 0.87% (2/231) | 4.01 | 0.006782 | 0.03156 |
GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 1.3% (3/231) | 2.97 | 0.006797 | 0.031595 |
GO:0048193 | Golgi vesicle transport | 3.03% (7/231) | 1.68 | 0.006739 | 0.031652 |
GO:0032388 | positive regulation of intracellular transport | 1.73% (4/231) | 2.41 | 0.006971 | 0.032367 |
GO:0048729 | tissue morphogenesis | 2.16% (5/231) | 2.07 | 0.007046 | 0.032607 |
GO:0034504 | protein localization to nucleus | 2.16% (5/231) | 2.07 | 0.007046 | 0.032607 |
GO:0003713 | transcription coactivator activity | 2.16% (5/231) | 2.07 | 0.007046 | 0.032607 |
GO:0017076 | purine nucleotide binding | 10.82% (25/231) | 0.76 | 0.007069 | 0.032674 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 1.3% (3/231) | 2.94 | 0.00709 | 0.032698 |
GO:0003012 | muscle system process | 1.3% (3/231) | 2.94 | 0.00709 | 0.032698 |
GO:0005635 | nuclear envelope | 2.16% (5/231) | 2.07 | 0.007191 | 0.033091 |
GO:0051783 | regulation of nuclear division | 2.16% (5/231) | 2.07 | 0.007191 | 0.033091 |
GO:0051301 | cell division | 4.33% (10/231) | 1.33 | 0.007248 | 0.033316 |
GO:0031057 | negative regulation of histone modification | 1.73% (4/231) | 2.39 | 0.007359 | 0.033786 |
GO:0061001 | regulation of dendritic spine morphogenesis | 0.87% (2/231) | 3.94 | 0.007431 | 0.033814 |
GO:0006337 | nucleosome disassembly | 0.87% (2/231) | 3.94 | 0.007431 | 0.033814 |
GO:1902692 | regulation of neuroblast proliferation | 0.87% (2/231) | 3.94 | 0.007431 | 0.033814 |
GO:0070122 | obsolete isopeptidase activity | 0.87% (2/231) | 3.94 | 0.007431 | 0.033814 |
GO:0097157 | pre-mRNA intronic binding | 0.87% (2/231) | 3.94 | 0.007431 | 0.033814 |
GO:0031974 | membrane-enclosed lumen | 5.19% (12/231) | 1.18 | 0.007429 | 0.033996 |
GO:0043233 | organelle lumen | 5.19% (12/231) | 1.18 | 0.007429 | 0.033996 |
GO:0070013 | intracellular organelle lumen | 5.19% (12/231) | 1.18 | 0.007429 | 0.033996 |
GO:1903706 | regulation of hemopoiesis | 1.73% (4/231) | 2.38 | 0.007558 | 0.034354 |
GO:0051241 | negative regulation of multicellular organismal process | 5.63% (13/231) | 1.12 | 0.007584 | 0.034435 |
GO:0005844 | polysome | 1.3% (3/231) | 2.9 | 0.007698 | 0.034876 |
GO:0070076 | histone lysine demethylation | 1.3% (3/231) | 2.9 | 0.007698 | 0.034876 |
GO:0048471 | perinuclear region of cytoplasm | 3.46% (8/231) | 1.51 | 0.007728 | 0.034973 |
GO:0018193 | peptidyl-amino acid modification | 5.63% (13/231) | 1.11 | 0.007824 | 0.035367 |
GO:0044089 | positive regulation of cellular component biogenesis | 2.6% (6/231) | 1.8 | 0.00795 | 0.035895 |
GO:0034728 | nucleosome organization | 1.73% (4/231) | 2.36 | 0.007967 | 0.035934 |
GO:0071479 | cellular response to ionizing radiation | 1.3% (3/231) | 2.88 | 0.008014 | 0.036105 |
GO:0000183 | rDNA heterochromatin formation | 0.87% (2/231) | 3.88 | 0.008107 | 0.036327 |
GO:0007616 | long-term memory | 0.87% (2/231) | 3.88 | 0.008107 | 0.036327 |
GO:2000637 | positive regulation of miRNA-mediated gene silencing | 0.87% (2/231) | 3.88 | 0.008107 | 0.036327 |
GO:0001764 | neuron migration | 0.87% (2/231) | 3.88 | 0.008107 | 0.036327 |
GO:0019901 | protein kinase binding | 3.9% (9/231) | 1.39 | 0.008081 | 0.036371 |
GO:0009653 | anatomical structure morphogenesis | 13.85% (32/231) | 0.64 | 0.008236 | 0.036866 |
GO:0031396 | regulation of protein ubiquitination | 2.16% (5/231) | 2.02 | 0.008265 | 0.036951 |
GO:2000243 | positive regulation of reproductive process | 3.46% (8/231) | 1.49 | 0.008299 | 0.037065 |
GO:0043405 | regulation of MAP kinase activity | 1.3% (3/231) | 2.86 | 0.008336 | 0.037192 |
GO:0070887 | cellular response to chemical stimulus | 12.12% (28/231) | 0.69 | 0.008541 | 0.038064 |
GO:0007034 | vacuolar transport | 2.6% (6/231) | 1.78 | 0.008604 | 0.0383 |
GO:0016577 | histone demethylation | 1.3% (3/231) | 2.84 | 0.008667 | 0.038498 |
GO:0000794 | condensed nuclear chromosome | 1.3% (3/231) | 2.84 | 0.008667 | 0.038498 |
GO:0021510 | spinal cord development | 0.87% (2/231) | 3.82 | 0.00881 | 0.038714 |
GO:0031000 | response to caffeine | 0.87% (2/231) | 3.82 | 0.00881 | 0.038714 |
GO:0042220 | response to cocaine | 0.87% (2/231) | 3.82 | 0.00881 | 0.038714 |
GO:0045428 | regulation of nitric oxide biosynthetic process | 0.87% (2/231) | 3.82 | 0.00881 | 0.038714 |
GO:0045685 | regulation of glial cell differentiation | 0.87% (2/231) | 3.82 | 0.00881 | 0.038714 |
GO:0007291 | sperm individualization | 0.87% (2/231) | 3.82 | 0.00881 | 0.038714 |
GO:0032453 | histone H3-methyl-lysine-4 demethylase activity | 0.87% (2/231) | 3.82 | 0.00881 | 0.038714 |
GO:0033169 | histone H3-K9 demethylation | 0.87% (2/231) | 3.82 | 0.00881 | 0.038714 |
GO:0035335 | peptidyl-tyrosine dephosphorylation | 0.87% (2/231) | 3.82 | 0.00881 | 0.038714 |
GO:0035239 | tube morphogenesis | 1.73% (4/231) | 2.32 | 0.008828 | 0.03875 |
GO:0003690 | double-stranded DNA binding | 9.52% (22/231) | 0.79 | 0.008857 | 0.03884 |
GO:0008168 | methyltransferase activity | 3.46% (8/231) | 1.47 | 0.008798 | 0.03904 |
GO:0016779 | nucleotidyltransferase activity | 2.16% (5/231) | 1.99 | 0.008925 | 0.039095 |
GO:0060491 | regulation of cell projection assembly | 1.3% (3/231) | 2.82 | 0.009005 | 0.039318 |
GO:0120032 | regulation of plasma membrane bounded cell projection assembly | 1.3% (3/231) | 2.82 | 0.009005 | 0.039318 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 1.3% (3/231) | 2.82 | 0.009005 | 0.039318 |
GO:0008276 | protein methyltransferase activity | 1.73% (4/231) | 2.3 | 0.009052 | 0.039439 |
GO:0051348 | negative regulation of transferase activity | 1.73% (4/231) | 2.3 | 0.009052 | 0.039439 |
GO:0071219 | cellular response to molecule of bacterial origin | 1.3% (3/231) | 2.8 | 0.00935 | 0.040654 |
GO:0050685 | positive regulation of mRNA processing | 1.3% (3/231) | 2.8 | 0.00935 | 0.040654 |
GO:0008494 | translation activator activity | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0071243 | cellular response to arsenic-containing substance | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0005677 | chromatin silencing complex | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0070569 | uridylyltransferase activity | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0003007 | heart morphogenesis | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0034198 | cellular response to amino acid starvation | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0003968 | RNA-directed 5'-3' RNA polymerase activity | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0005685 | U1 snRNP | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0035145 | exon-exon junction complex | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0034643 | establishment of mitochondrion localization, microtubule-mediated | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0017070 | U6 snRNA binding | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0050771 | negative regulation of axonogenesis | 0.87% (2/231) | 3.76 | 0.009539 | 0.040909 |
GO:0004518 | nuclease activity | 3.03% (7/231) | 1.58 | 0.009583 | 0.041058 |
GO:0008234 | cysteine-type peptidase activity | 2.16% (5/231) | 1.96 | 0.009621 | 0.041178 |
GO:0051962 | positive regulation of nervous system development | 1.73% (4/231) | 2.28 | 0.009511 | 0.04131 |
GO:0046883 | regulation of hormone secretion | 1.3% (3/231) | 2.78 | 0.009704 | 0.0414 |
GO:0090087 | regulation of peptide transport | 1.3% (3/231) | 2.78 | 0.009704 | 0.0414 |
GO:0008408 | 3'-5' exonuclease activity | 1.3% (3/231) | 2.78 | 0.009704 | 0.0414 |
GO:0051668 | localization within membrane | 3.46% (8/231) | 1.44 | 0.010202 | 0.043479 |
GO:0008175 | tRNA methyltransferase activity | 0.87% (2/231) | 3.7 | 0.010294 | 0.043781 |
GO:0051654 | establishment of mitochondrion localization | 0.87% (2/231) | 3.7 | 0.010294 | 0.043781 |
GO:0001894 | tissue homeostasis | 1.3% (3/231) | 2.74 | 0.010433 | 0.044237 |
GO:0006482 | protein demethylation | 1.3% (3/231) | 2.74 | 0.010433 | 0.044237 |
GO:0008214 | protein dealkylation | 1.3% (3/231) | 2.74 | 0.010433 | 0.044237 |
GO:0016462 | pyrophosphatase activity | 3.46% (8/231) | 1.43 | 0.010665 | 0.045127 |
GO:0005102 | signaling receptor binding | 3.46% (8/231) | 1.43 | 0.010665 | 0.045127 |
GO:0008170 | N-methyltransferase activity | 1.73% (4/231) | 2.23 | 0.010726 | 0.045291 |
GO:0000724 | double-strand break repair via homologous recombination | 1.73% (4/231) | 2.23 | 0.010726 | 0.045291 |
GO:0072657 | protein localization to membrane | 3.03% (7/231) | 1.55 | 0.010747 | 0.045332 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3.46% (8/231) | 1.42 | 0.010784 | 0.045393 |
GO:0048589 | developmental growth | 8.23% (19/231) | 0.84 | 0.010775 | 0.045404 |
GO:0001650 | fibrillar center | 1.3% (3/231) | 2.72 | 0.01081 | 0.045457 |
GO:0032239 | regulation of nucleobase-containing compound transport | 0.87% (2/231) | 3.65 | 0.011074 | 0.046332 |
GO:0021987 | cerebral cortex development | 0.87% (2/231) | 3.65 | 0.011074 | 0.046332 |
GO:0014015 | positive regulation of gliogenesis | 0.87% (2/231) | 3.65 | 0.011074 | 0.046332 |
GO:0090306 | meiotic spindle assembly | 0.87% (2/231) | 3.65 | 0.011074 | 0.046332 |
GO:0048699 | generation of neurons | 0.87% (2/231) | 3.65 | 0.011074 | 0.046332 |
GO:1990778 | protein localization to cell periphery | 2.16% (5/231) | 1.91 | 0.011124 | 0.046494 |
GO:0002164 | larval development | 1.3% (3/231) | 2.7 | 0.011194 | 0.04669 |
GO:0006446 | regulation of translational initiation | 1.3% (3/231) | 2.7 | 0.011194 | 0.04669 |
GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0035874 | cellular response to copper ion starvation | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0120126 | response to copper ion starvation | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0036333 | hepatocyte homeostasis | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:1904772 | response to tetrachloromethane | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:1990275 | preribosome binding | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0007443 | Malpighian tubule morphogenesis | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0007510 | cardioblast cell fate determination | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0060913 | cardiac cell fate determination | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0035025 | positive regulation of Rho protein signal transduction | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:1905356 | regulation of snRNA pseudouridine synthesis | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0045346 | regulation of MHC class II biosynthetic process | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0045347 | negative regulation of MHC class II biosynthetic process | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0032576 | O-linoleoyltransferase activity | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0032577 | phosphatidylcholine:cardiolipin O-linoleoyltransferase activity | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0018262 | isopeptide cross-linking | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0098833 | presynaptic endocytic zone | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:1905274 | regulation of modification of postsynaptic actin cytoskeleton | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:2001286 | regulation of caveolin-mediated endocytosis | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:2001288 | positive regulation of caveolin-mediated endocytosis | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0005053 | peroxisome matrix targeting signal-2 binding | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0070939 | Dsl1/NZR complex | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0032995 | regulation of fungal-type cell wall biogenesis | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:1990646 | cellular response to prolactin | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0099053 | activating signal cointegrator 1 complex | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0062152 | mRNA (cytidine-5-)-methyltransferase activity | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0030870 | Mre11 complex | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0110025 | DNA strand resection involved in replication fork processing | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:1990898 | meiotic DNA double-strand break clipping | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0036228 | protein localization to nuclear inner membrane | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0007028 | cytoplasm organization | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0110026 | regulation of DNA strand resection involved in replication fork processing | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0110027 | negative regulation of DNA strand resection involved in replication fork processing | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0001977 | renal system process involved in regulation of blood volume | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0002548 | monocyte chemotaxis | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0003093 | regulation of glomerular filtration | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0022038 | corpus callosum development | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0048681 | negative regulation of axon regeneration | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0070571 | negative regulation of neuron projection regeneration | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0098801 | regulation of renal system process | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:1905874 | regulation of postsynaptic density organization | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:1990264 | peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0000417 | HIR complex | 0.43% (1/231) | 6.4 | 0.011785 | 0.046774 |
GO:0000725 | recombinational repair | 1.73% (4/231) | 2.21 | 0.011239 | 0.046829 |
GO:0016514 | SWI/SNF complex | 0.87% (2/231) | 3.6 | 0.01188 | 0.046926 |
GO:0007095 | mitotic G2 DNA damage checkpoint signaling | 0.87% (2/231) | 3.6 | 0.01188 | 0.046926 |
GO:0051447 | negative regulation of meiotic cell cycle | 0.87% (2/231) | 3.6 | 0.01188 | 0.046926 |
GO:0051897 | positive regulation of protein kinase B signaling | 0.87% (2/231) | 3.6 | 0.01188 | 0.046926 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 0.87% (2/231) | 3.6 | 0.01188 | 0.046926 |
GO:0043462 | regulation of ATP-dependent activity | 1.3% (3/231) | 2.67 | 0.011986 | 0.047207 |
GO:0031100 | animal organ regeneration | 1.3% (3/231) | 2.67 | 0.011986 | 0.047207 |
GO:0000381 | regulation of alternative mRNA splicing, via spliceosome | 1.3% (3/231) | 2.67 | 0.011986 | 0.047207 |
GO:0030684 | preribosome | 1.73% (4/231) | 2.18 | 0.012037 | 0.047317 |
GO:0006275 | regulation of DNA replication | 1.73% (4/231) | 2.18 | 0.012037 | 0.047317 |
GO:0003824 | catalytic activity | 40.26% (93/231) | 0.29 | 0.012174 | 0.04781 |
GO:0010078 | maintenance of root meristem identity | 1.73% (4/231) | 2.2 | 0.011501 | 0.047824 |
GO:0071702 | organic substance transport | 9.96% (23/231) | 0.74 | 0.0115 | 0.04787 |
GO:0090575 | RNA polymerase II transcription regulator complex | 1.73% (4/231) | 2.17 | 0.012311 | 0.048301 |
GO:0051090 | regulation of DNA-binding transcription factor activity | 2.16% (5/231) | 1.87 | 0.012352 | 0.048414 |
GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.3% (3/231) | 2.65 | 0.012394 | 0.048534 |
GO:0006914 | autophagy | 2.16% (5/231) | 1.89 | 0.011727 | 0.048714 |
GO:0061919 | process utilizing autophagic mechanism | 2.16% (5/231) | 1.87 | 0.012565 | 0.049156 |
GO:0045597 | positive regulation of cell differentiation | 3.03% (7/231) | 1.5 | 0.012604 | 0.049264 |
GO:0042766 | obsolete nucleosome mobilization | 0.87% (2/231) | 3.54 | 0.012711 | 0.049399 |
GO:0005662 | DNA replication factor A complex | 0.87% (2/231) | 3.54 | 0.012711 | 0.049399 |
GO:0048520 | positive regulation of behavior | 0.87% (2/231) | 3.54 | 0.012711 | 0.049399 |
GO:0001960 | negative regulation of cytokine-mediated signaling pathway | 0.87% (2/231) | 3.54 | 0.012711 | 0.049399 |
GO:1900153 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 0.87% (2/231) | 3.54 | 0.012711 | 0.049399 |
GO:0051963 | regulation of synapse assembly | 0.87% (2/231) | 3.54 | 0.012711 | 0.049399 |